SlideShare a Scribd company logo
Pathology of thePathology of the
Nervous SystemNervous System
Karen SantaCruz MDKaren SantaCruz MD
Brent Clark MD, PhDBrent Clark MD, PhD
Pathology of the Nervous SystemPathology of the Nervous System
 IntroductionIntroduction
 IncreasedIncreased
intracranialintracranial
pressurepressure
 Vascular andVascular and
circulatorycirculatory
disordersdisorders
 TraumaTrauma
 InfectionsInfections
 TumorsTumors
 DemyelinatingDemyelinating
diseasesdiseases
 DegenerativeDegenerative
diseasesdiseases
 DevelopmentalDevelopmental
AbnormalitiesAbnormalities
Hematoxylin and Eosin Luxol fast-blue-PASLuxol fast-blue-PAS
BielschowskyBielschowsky
Cell typesCell types
1.1. Neuron:Neuron: functions in neural transmission, mostfunctions in neural transmission, most
vulnerable cell, limited regenerationvulnerable cell, limited regeneration
2.2. AstrocyteAstrocyte: major reactive cell of CNS forms ‘scar’: major reactive cell of CNS forms ‘scar’
3.3. OligodendrocyteOligodendrocyte: highly vulnerable, limited: highly vulnerable, limited
proliferation, forms myelin sheathproliferation, forms myelin sheath
4.4. Ependymal cellEpendymal cell: vulnerable, limited regeneration,: vulnerable, limited regeneration,
lines ventricles (ependymal granulations)lines ventricles (ependymal granulations)
5.5. Microglial cellMicroglial cell: monocyte/macrophage (bone: monocyte/macrophage (bone
marrow) derived phagocytic cell, antigenmarrow) derived phagocytic cell, antigen
presentation, producer of cytokines,presentation, producer of cytokines,
inflammatory cellinflammatory cell
IntroductionIntroduction
 Cellular reactions of the central nervous systemCellular reactions of the central nervous system
 Neurons: permanentNeurons: permanent
 Axonal retraction (axonal spheroids)Axonal retraction (axonal spheroids)
 Ischemic cell changesIschemic cell changes
 Atrophy and degenerationAtrophy and degeneration
 Intraneuronal deposits and inclusionsIntraneuronal deposits and inclusions
(neurodegenerative diseases)(neurodegenerative diseases)
 Glia: proliferate, form glial ‘scar’Glia: proliferate, form glial ‘scar’
Gray MatterGray Matter
Nissl substanceNissl substance
White MatterWhite Matter
Ventricular liningVentricular lining
Mechanisms of dysfunction causingMechanisms of dysfunction causing
diseasedisease
 Pathophysiological (toxic/metabolic)Pathophysiological (toxic/metabolic)
 StructuralStructural
Focal lesions correlate with localizing symptomsFocal lesions correlate with localizing symptoms
System degenerations correlate with functionallySystem degenerations correlate with functionally
localizing symptoms (ie motor neuron disease)localizing symptoms (ie motor neuron disease)
 Increased intracranial pressure (generalized orIncreased intracranial pressure (generalized or
focal), can cause global symptoms or brainfocal), can cause global symptoms or brain
herniation since the volume of the brain is fixed byherniation since the volume of the brain is fixed by
the skullthe skull
Increased intracranialIncreased intracranial
pressurepressure
HeadacheHeadache
VomitingVomiting
Decreased Level of ConsciousnessDecreased Level of Consciousness
PapilledemaPapilledema
HerniationHerniation
Causes of Cerebral EdemaCauses of Cerebral Edema
 GeneralizedGeneralized
(frequently(frequently
cytotoxic)cytotoxic)
 HypoxiaHypoxia
 ToxinsToxins
 EncephalitisEncephalitis
 TraumaTrauma
 Focal (often vasogenic)Focal (often vasogenic)
 InfarctionInfarction
 Injury/contusionInjury/contusion
 Mass—neoplastic,Mass—neoplastic,
infectious (cerebralinfectious (cerebral
abscess), hematomaabscess), hematoma
TYPES OF HERNIATIONTYPES OF HERNIATION
1.1. SubfalcineSubfalcine
(cingulate)(cingulate)
2.2. TranstentorialTranstentorial
(uncal)(uncal)
3.3. TonsillarTonsillar
(foramen(foramen
magnum)magnum)
4.4. ExtracranialExtracranial
TRANSTENTORIAL (UNCAL)TRANSTENTORIAL (UNCAL)
HERNIATIONHERNIATION
SHIFT OF THE BRAIN FROM THE MIDDLE TOSHIFT OF THE BRAIN FROM THE MIDDLE TO
THE POSTERIOR FOSSA THROUGH THETHE POSTERIOR FOSSA THROUGH THE
TENTORIAL INCISURATENTORIAL INCISURA
MAY BE UNILATERAL OR “CENTRAL”MAY BE UNILATERAL OR “CENTRAL”
SECONDARY EFFECTS INCLUDE:SECONDARY EFFECTS INCLUDE:
Compression of the third cranial nerve(s)Compression of the third cranial nerve(s)
Duret hemorrhages in midline rostral brainstemDuret hemorrhages in midline rostral brainstem
Compression of the contralateral cerebral peduncleCompression of the contralateral cerebral peduncle
(Kernohan’s notch)(Kernohan’s notch)
Compression of the posterior cerebral artery withCompression of the posterior cerebral artery with
infarction of the medial occipital lobeinfarction of the medial occipital lobe
UNCAL HERNIATIONUNCAL HERNIATION
Normal uncusNormal uncus Herniated rightHerniated right
uncusuncus
DURET HEMORRHAGESDURET HEMORRHAGES
Midline Duret hemorrhages plus Kernohan’sMidline Duret hemorrhages plus Kernohan’s
notch in the right cerebral pedunclenotch in the right cerebral peduncle
HYDROCEPHALUSHYDROCEPHALUS
DILATATION OF THE VENTRICULARDILATATION OF THE VENTRICULAR
SYSTEMSYSTEM
NONCOMMUNICATING: Due toNONCOMMUNICATING: Due to
obstruction within the ventricular system,obstruction within the ventricular system,
e.g., tumor, aqueductal stenosise.g., tumor, aqueductal stenosis
COMMUNICATING: Due to obstruction ofCOMMUNICATING: Due to obstruction of
CSF flow in the subarachnoid space withCSF flow in the subarachnoid space with
decreased reabsorptiondecreased reabsorption
CSFCSF
FLOWFLOW
COMMUNICATINGCOMMUNICATING
HYDROCEPHALUSHYDROCEPHALUS
Dilatation of the entire ventricular system including theDilatation of the entire ventricular system including the
aqueduct and fourth ventricular foramina. There isaqueduct and fourth ventricular foramina. There is
thickening and scarring of the meninges, secondary tothickening and scarring of the meninges, secondary to
previous subarachnoid hemorrhageprevious subarachnoid hemorrhage
Summary: Microscopic and grossSummary: Microscopic and gross
brain abnormalitiesbrain abnormalities
 Cell types: Function and proliferative capacityCell types: Function and proliferative capacity
 Mechanisms of CNS dysfunction:Mechanisms of CNS dysfunction:
 Pathophysiological “invisible” lesions: metabolic, toxicPathophysiological “invisible” lesions: metabolic, toxic
 Structural “visible” abnormalities: mass, edema,Structural “visible” abnormalities: mass, edema,
hydrocephalus, cytologic abnormalities.hydrocephalus, cytologic abnormalities.
 Increased intracranial pressureIncreased intracranial pressure
 Causes of cerebral edema: focal and generalizedCauses of cerebral edema: focal and generalized
 Types of herniation: cingulate, uncal, tonsillarTypes of herniation: cingulate, uncal, tonsillar
 Hydrocephalus: non-communicating and communicatingHydrocephalus: non-communicating and communicating
Vascular andVascular and
Circulatory DisordersCirculatory Disorders
Ischemia/InfarctionIschemia/Infarction
Transient Ischemic AttacksTransient Ischemic Attacks
HemorrhageHemorrhage
Stroke: Ischemia/InfarctStroke: Ischemia/Infarct
 Atherosclerosis: NarrowingAtherosclerosis: Narrowing
 Thrombosis: Damages vessel, infarcts areThrombosis: Damages vessel, infarcts are
non-hemorrhagicnon-hemorrhagic
 Embolism: Heart valves, plaquesEmbolism: Heart valves, plaques
(frequently hemorrhagic)(frequently hemorrhagic)
 Vasospasm: Rare, but common afterVasospasm: Rare, but common after
subarachnoid hemorrhagesubarachnoid hemorrhage
 Hypertensive vasculopathy: LacunarHypertensive vasculopathy: Lacunar
infarctsinfarcts
RISK FACTORSRISK FACTORS
atherosclerosisatherosclerosis
RISK FACTOR: atherosclerosisRISK FACTOR: atherosclerosis
EMBOLIC INFARCTSEMBOLIC INFARCTS
TYPICALLYTYPICALLY
ARE HEMORRHAGICARE HEMORRHAGIC
RISK FACTORS:RISK FACTORS:
hypertension (lacunar infarcts)hypertension (lacunar infarcts)
Lacunar infarct of theLacunar infarct of the
globus pallidusglobus pallidus
Lacunar infarct of theLacunar infarct of the
ponspons
Other causes of ischemiaOther causes of ischemia
 Systemic Hypotension: Results in watershedSystemic Hypotension: Results in watershed
infarctsinfarcts
 Hypoxia or Anoxia: Lack of oxygen or poorHypoxia or Anoxia: Lack of oxygen or poor
perfusion after MI results in watershed infarctsperfusion after MI results in watershed infarcts
and/or damage in vulnerable regions, ieand/or damage in vulnerable regions, ie
hippocampus and cerebellumhippocampus and cerebellum
 Venous thrombosis: Rare, causes hemorrhagicVenous thrombosis: Rare, causes hemorrhagic
infarcts, consider coagulopathyinfarcts, consider coagulopathy
ANASTOMOSES BETWEENANASTOMOSES BETWEEN
TERMINAL BRANCHES OFTERMINAL BRANCHES OF
MAJOR CEREBRAL ARTERIESMAJOR CEREBRAL ARTERIES
VASCULAR WATERSHEDSVASCULAR WATERSHEDS
VENOUSVENOUS
CIRCULATIONCIRCULATION
VENOUS INFARCTIONVENOUS INFARCTION
 Venous infarction usuallyVenous infarction usually
results from venous sinusresults from venous sinus
thrombosisthrombosis
 Risk factors include aRisk factors include a
number of states thatnumber of states that
result in hyperviscosityresult in hyperviscosity
or increased coagulabilityor increased coagulability
 Grossly they are veryGrossly they are very
hemorrhagichemorrhagic
Transient Ischemic AttacksTransient Ischemic Attacks
 Lasts less than 24 hours by definitionLasts less than 24 hours by definition
 Attributed to transient embolizationAttributed to transient embolization
 Occurs in patients with atheroscleroticOccurs in patients with atherosclerotic
stenosisstenosis
 Harbinger of cerebral infarctionHarbinger of cerebral infarction
Summary: Strokes due toSummary: Strokes due to
ischemia/infarctionischemia/infarction
 Large vessel atherosclerotic disease (non-Large vessel atherosclerotic disease (non-
hemorrhagic)hemorrhagic)
 Embolic (hemorrhagic)Embolic (hemorrhagic)
 Hypertensive (hemorrhages and lacunes)Hypertensive (hemorrhages and lacunes)
 Vasospasm (2° to subarachnoid hemorrhage)Vasospasm (2° to subarachnoid hemorrhage)
 Watershed infarcts: hypotension and hypoxiaWatershed infarcts: hypotension and hypoxia
 Venous thrombosis (rare, hemorrhagic)Venous thrombosis (rare, hemorrhagic)
 TIA: clears in 24 hours -by definition, oftenTIA: clears in 24 hours -by definition, often
associated with large vessel diseaseassociated with large vessel disease
Strokes Due toStrokes Due to
HemorrhageHemorrhage
HypertensionHypertension
AneurysmsAneurysms
Vascular MalformationsVascular Malformations
Bleeding DiathesisBleeding Diathesis
TraumaTrauma
HYPERTENSIVEHYPERTENSIVE
HEMORRHAGEHEMORRHAGE
lenticulostriate arterieslenticulostriate arteries
SACCULAR ANEURYSMSSACCULAR ANEURYSMS
SUBARACHNOID HEMORRHAGESUBARACHNOID HEMORRHAGE
rupture of saccular (berry) aneurysmrupture of saccular (berry) aneurysm
MYCOTIC ANEURYSMMYCOTIC ANEURYSM
(bacterial)
VASCULAR MALFORMATIONVASCULAR MALFORMATION
AS A SOURCE OF HEMORRHAGEAS A SOURCE OF HEMORRHAGE
arteriovenous malformation (AVM)arteriovenous malformation (AVM)
BLOOD DYSCRASIASBLOOD DYSCRASIAS
AS A CAUSE OF HEMORRHAGEAS A CAUSE OF HEMORRHAGE
thrombocytopeniathrombocytopenia
Summary: Strokes due toSummary: Strokes due to
hemorrhagehemorrhage
 Hypertension: Most common cause of brainHypertension: Most common cause of brain
hemorrhage, sites include basal ganglia, pons,hemorrhage, sites include basal ganglia, pons,
cerebellum and cerebral white mattercerebellum and cerebral white matter
 Aneurysms:Aneurysms:
 Berry aneurysm: Most common type, causesBerry aneurysm: Most common type, causes SAHSAH
 Mycotic aneurysm: Rare, parenchymal bleed, bacterialMycotic aneurysm: Rare, parenchymal bleed, bacterial
 Atherosclerotic: Rarely bleed, may cause mass effect,Atherosclerotic: Rarely bleed, may cause mass effect,
fusiformfusiform
 Vascular malformations and clottingVascular malformations and clotting
abnormalitiesabnormalities
Closed Head InjuryClosed Head Injury
ConcussionConcussion
 Immediate and temporary disturbance of brainImmediate and temporary disturbance of brain
function.function.
 Grading (1.Grading (1. mildmild: no LOC/smpt <15 min, 2.: no LOC/smpt <15 min, 2.
modmod: no LOC/smpt >15min, 3.: no LOC/smpt >15min, 3. severesevere: any LOC): any LOC)
 CauseCause
 Shearing of axonsShearing of axons
 Signs: Amnesia, confusion, headache, visualSigns: Amnesia, confusion, headache, visual
disturbances, nausea, vomiting, dizzinessdisturbances, nausea, vomiting, dizziness
Closed Head InjuryClosed Head Injury
 Epidural hematomaEpidural hematoma: Middle meningeal artery: Middle meningeal artery
tear (temporal bone fracture), accumulatestear (temporal bone fracture), accumulates
rapidly (arterial)rapidly (arterial)
 Subdural hematomaSubdural hematoma: Shearing of bridging: Shearing of bridging
veins, accumulate in hours to days (rarelyveins, accumulate in hours to days (rarely
weeks+)weeks+)
 Subarachnoid hemorrhageSubarachnoid hemorrhage: Occurs with: Occurs with
contusions or intraparenchymal hemorrhagecontusions or intraparenchymal hemorrhage
(also with berry aneurysms)(also with berry aneurysms)
TRAUMA AS A CAUSE OFTRAUMA AS A CAUSE OF
HEMORRHAGEHEMORRHAGE
subdural hematomasubdural hematoma
Closed Head InjuryClosed Head Injury
 ContusionsContusions: Brain against bone, coup (at site: Brain against bone, coup (at site
of impact)/contrecoup (side opposite impact)of impact)/contrecoup (side opposite impact)
 Intracerebral hemorrhageIntracerebral hemorrhage: Shearing of brain: Shearing of brain
vessels, high impactvessels, high impact
 Diffuse Axonal InjuryDiffuse Axonal Injury: Shearing of axons: Shearing of axons
results in post-traumatic neurologic deficitsresults in post-traumatic neurologic deficits
 Cerebral EdemaCerebral Edema: Occurs with and without an: Occurs with and without an
obvious structural lesionobvious structural lesion
 Note: Can occur without evidence of hemorrhageNote: Can occur without evidence of hemorrhage
TRAUMA AS A CAUSE OFTRAUMA AS A CAUSE OF
HEMORRHAGE: contusionsHEMORRHAGE: contusions
Other traumatic injuriesOther traumatic injuries
 Penetrating injuries: Bullets, bone fragments,Penetrating injuries: Bullets, bone fragments,
result in laceration with the potential forresult in laceration with the potential for
infectioninfection
 Spinal cord injury: Fractures, vertebralSpinal cord injury: Fractures, vertebral
dislocation, penetrating injury, the spinal corddislocation, penetrating injury, the spinal cord
may be crushed or the site of hemorrhagemay be crushed or the site of hemorrhage
Summary: TraumaSummary: Trauma
 Closed head injuries:Closed head injuries:
 Sites (epidural, subdural, subarachnoid,Sites (epidural, subdural, subarachnoid,
parenchymal) and typical etiologyparenchymal) and typical etiology
 Contusion, hemorrhage, diffuse axonal injury,Contusion, hemorrhage, diffuse axonal injury,
edemaedema
 Penetrating injuries:Penetrating injuries:
 Causes and risks (infection)Causes and risks (infection)
 Spinal cord injuriesSpinal cord injuries
InfectionsInfections
MeningitisMeningitis
BacterialBacterial
TuberculousTuberculous
FungalFungal
ViralViral
Cerebral abscessCerebral abscess
SubduralSubdural
empyemaempyema
CerebritisCerebritis
Viral encephalitisViral encephalitis
Infections: Route of entryInfections: Route of entry
 Hematogenous (most common)Hematogenous (most common)
 Localized source: abscess, heart valve, lung infectionLocalized source: abscess, heart valve, lung infection
 Other: mosquitos, needlesOther: mosquitos, needles
 Direct implantation (trauma)Direct implantation (trauma)
 Local extension (ear infectionLocal extension (ear infection abscess)abscess)
 Axonal transport (rabies, HSV)Axonal transport (rabies, HSV)
MeningitisMeningitis
 Inflammation of the meningesInflammation of the meninges
 FeverFever
 HeadacheHeadache
 Stiff neckStiff neck
 Decreased level of consciousnessDecreased level of consciousness
 Bacterial (purulent)Bacterial (purulent)
 Tuberculous (granulomatous)Tuberculous (granulomatous)
 Fungal (granulomatous)Fungal (granulomatous)
Bacterial MeningitisBacterial Meningitis
 Neonates: E. Coli, group B streptococciNeonates: E. Coli, group B streptococci
 Infants and children: Hemophilus influenzaInfants and children: Hemophilus influenza
(before immunization)(before immunization)
 Young adults: Neisseria meningitidisYoung adults: Neisseria meningitidis
 Adults: Streptococcus pneumoniae and ListeriaAdults: Streptococcus pneumoniae and Listeria
monocytogenesmonocytogenes
Meningitis: CSF findingsMeningitis: CSF findings
 Increased white blood cellsIncreased white blood cells
 Neutrophils withNeutrophils with bacterialbacterial meningitismeningitis
 Mononuclear cells (lymphocytes andMononuclear cells (lymphocytes and
macrophages) withmacrophages) with TB and fungalTB and fungal infectionsinfections
 Lymphocytes withLymphocytes with viralviral infectioninfection
 Increased protein (mild with viral)Increased protein (mild with viral)
 Reduced glucose withReduced glucose with bacterialbacterial meningitismeningitis
PURULENT (BACTERIAL)PURULENT (BACTERIAL)
MENINGITISMENINGITIS
PURULENT MENINGITISPURULENT MENINGITIS
GRANULOMATOUS MENINGITIS:GRANULOMATOUS MENINGITIS:
tuberculosistuberculosis
GRANULOMATOUSGRANULOMATOUS
MENINGITISMENINGITIS
tuberculosistuberculosis
H&EH&E Acid FastAcid Fast
GRANULOMATOUSGRANULOMATOUS
MENINGITISMENINGITIS
tuberculosistuberculosis
Sequelae:Sequelae:
VasculitisVasculitis
Small infarctsSmall infarcts
Cranial neuropathiesCranial neuropathies
ASEPTIC (VIRAL)ASEPTIC (VIRAL)
MENINGITISMENINGITIS
Cerebral AbscessCerebral Abscess
 Localized (contained) infectionLocalized (contained) infection
 Hematogenous spread (heart valves), penetratingHematogenous spread (heart valves), penetrating
wound, paranasal sinuses, middle earwound, paranasal sinuses, middle ear
 Oral flora may be the source of an abscess afterOral flora may be the source of an abscess after
dental manipulationdental manipulation
 Organisms are mixed and frequently anaerobicOrganisms are mixed and frequently anaerobic
 Surrounding cerebral edema is commonSurrounding cerebral edema is common
 CSF is frequently sterileCSF is frequently sterile
PURULENT CEREBRALPURULENT CEREBRAL
ABSCESSABSCESS
Cerebritis in Immune-compromisedCerebritis in Immune-compromised
PatientsPatients
 Fungal InfectionsFungal Infections
 AspergillusAspergillus
 CandidaCandida
 MucorMucor
 ProtozoalProtozoal
 ToxoplasmaToxoplasma
 Ameba infections can be seen inAmeba infections can be seen in
immunocompromised patients and rarelyimmunocompromised patients and rarely
non-immunocompromised individualsnon-immunocompromised individuals
Viral infectionViral infection
 Route of entryRoute of entry
 May be blood borne, respiratory or fecal/oralMay be blood borne, respiratory or fecal/oral
 Rabies-peripheral nerveRabies-peripheral nerve
 Acute viral encephalitisAcute viral encephalitis
 Herpes-activation of latent infectionHerpes-activation of latent infection
 Arbovirus-mosquito borne (West Nile virus)Arbovirus-mosquito borne (West Nile virus)
 Polio-enteric virus with neuronal tropismPolio-enteric virus with neuronal tropism
 Immunocompromised hostsImmunocompromised hosts
 CMVCMV
 HSV/VZVHSV/VZV
 PMLPML
 HIV encephalitis (HIVE)HIV encephalitis (HIVE)
ACUTE (VIRAL) ENCEPHALITISACUTE (VIRAL) ENCEPHALITIS
microscopic featuresmicroscopic features
Lymphocytic infiltratesLymphocytic infiltrates Microglial proliferationMicroglial proliferation
with microglial noduleswith microglial nodules
ACUTE (VIRAL) ENCEPHALITISACUTE (VIRAL) ENCEPHALITIS
Herpes simplexHerpes simplex
OPPORTUNISTIC VIRAL INFECTIONS:OPPORTUNISTIC VIRAL INFECTIONS:
Progressive multifocal leukoencephalopathyProgressive multifocal leukoencephalopathy
(JC virus)(JC virus)
Progressive multifocalProgressive multifocal
leukoencephalopathyleukoencephalopathy
OPPORTUNISTIC INFECTIONS:OPPORTUNISTIC INFECTIONS:
ToxoplasmosisToxoplasmosis
OPPORTUNISTICOPPORTUNISTIC
INFECTIONS: ToxoplasmosisINFECTIONS: Toxoplasmosis
Bradyzoites with cystsBradyzoites with cysts
OPPORTUNISTICOPPORTUNISTIC
INFECTIONSINFECTIONS
ToxoplasmosisToxoplasmosis
Necrotizing lesionNecrotizing lesion Immunoperoxidase forImmunoperoxidase for
H&EH&E Toxo. tachyzoitesToxo. tachyzoites
OPPORTUNISTIC INFECTIONSOPPORTUNISTIC INFECTIONS
Fungal cerebritis : AspergillusFungal cerebritis : Aspergillus
OPPORTUNISTIC INFECTIONSOPPORTUNISTIC INFECTIONS
Fungal cerebritis : AspergillusFungal cerebritis : Aspergillus
Summary: InfectionsSummary: Infections
 Meningitis: Definition, CSF findingsMeningitis: Definition, CSF findings
 Abscess: Definition, etiologyAbscess: Definition, etiology
 Viral meningitis: Routes of entry (arbo-Viral meningitis: Routes of entry (arbo-
mosquitos)mosquitos)
 Viral encephalitis: Rabies, HSV, arbovirusesViral encephalitis: Rabies, HSV, arboviruses
 Spinal cord: PolioSpinal cord: Polio
 Infections in immunocompromised hostsInfections in immunocompromised hosts
 Cerebritis: Fungal (aspergillus, protozoal-Cerebritis: Fungal (aspergillus, protozoal-
toxoplasma)toxoplasma)
 Viral: CMV, VZV, PML, Aids encephalopathyViral: CMV, VZV, PML, Aids encephalopathy
Primary Tumors of the CentralPrimary Tumors of the Central
Nervous SystemNervous System
GliomaGlioma
AstrocytomaAstrocytoma
OligodendrogliomaOligodendroglioma
EpendymomaEpendymoma
 Neuronal lineageNeuronal lineage
 MeningiomaMeningioma
 Nerve Sheath TumorsNerve Sheath Tumors
Primary brain tumors: Cell typesPrimary brain tumors: Cell types
1.1. Neuron:Neuron: Gangliocytoma, gangliogliomaGangliocytoma, ganglioglioma
medulloblastomamedulloblastoma
2.2. AstrocyteAstrocyte:: Astrocytoma, glioblastomaAstrocytoma, glioblastoma
3.3. OligodendrocyteOligodendrocyte:: OligodendrogliomaOligodendroglioma
4.4. Ependymal cellEpendymal cell:: EpendymomaEpendymoma
5.5. Microglial cellMicroglial cell:: Tumors derived from microglialTumors derived from microglial
cells have not been described.cells have not been described.
6.6. Meningeal cellMeningeal cell:: Meningiomas are derived fromMeningiomas are derived from
arachnoidal cells and are usually dural-based.arachnoidal cells and are usually dural-based.
GLIOMASGLIOMAS
 ASTROCYTOMASASTROCYTOMAS
 OLIGODENDROGLIOMASOLIGODENDROGLIOMAS
 EPENDYMOMASEPENDYMOMAS
 MIXED GLIOMASMIXED GLIOMAS
GliomasGliomas
 Diffusely infiltrating (not easily resected)Diffusely infiltrating (not easily resected)
 Histologic appearance (grade) correlates withHistologic appearance (grade) correlates with
overall survivaloverall survival
 May become more malignant (higher grade) overMay become more malignant (higher grade) over
time (especially astrocytomas which becometime (especially astrocytomas which become
glioblastomas)glioblastomas)
 May spread via CSFMay spread via CSF
 Rarely (never) metastasizeRarely (never) metastasize
JUVENILE PILOCYTICJUVENILE PILOCYTIC
ASTROCYTOMAASTROCYTOMA
JUVENILE PILOCYTICJUVENILE PILOCYTIC
ASTROCYTOMAASTROCYTOMA
Rosenthal fibersRosenthal fibers Eosinophilic granularEosinophilic granular
bodiesbodies
ASTROCYTOMAASTROCYTOMA
ASTROCYTOMAASTROCYTOMA
ASTROCYTOMAASTROCYTOMA
ASTROCYTOMAASTROCYTOMA
FEATURES OF ANAPLASIAFEATURES OF ANAPLASIA
vascular proliferationvascular proliferation
GLIOBLASTOMAGLIOBLASTOMA
MULTIFORMEMULTIFORME
GLIOBLASTOMAGLIOBLASTOMA
MULTIFORMEMULTIFORME
OLIGODENDROGLIOMAOLIGODENDROGLIOMA
EPENDYMOMAEPENDYMOMA
Non-glial tumorsNon-glial tumors
 Medulloblastoma: Malignant cerebellar tumorMedulloblastoma: Malignant cerebellar tumor
of childhoodof childhood
 Meningioma: Benign, superficial, well-Meningioma: Benign, superficial, well-
circumscribed tumor derived from arachnoidalcircumscribed tumor derived from arachnoidal
cellscells
 Nerve sheath tumors: Schwannoma andNerve sheath tumors: Schwannoma and
neurofibroma, well-circumscribed, encapsulatedneurofibroma, well-circumscribed, encapsulated
tumors involving cranial nerves, spinal nervestumors involving cranial nerves, spinal nerves
and other peripheral nervesand other peripheral nerves
MEDULLOBLASTOMAMEDULLOBLASTOMA
MEDULLOBLASTOMAMEDULLOBLASTOMA
MENINGIOMAMENINGIOMA
SCHWANNOMASCHWANNOMA
NEUROFIBROMANEUROFIBROMA
Secondary Involvement of theSecondary Involvement of the
Central Nervous SystemCentral Nervous System
 Metastatic tumorMetastatic tumor
 MelanomaMelanoma
 Renal cellRenal cell
 LungLung
 Contiguous involvement (pituitaryContiguous involvement (pituitary
adenoma and craniopharyngioma)adenoma and craniopharyngioma)
METASTATIC TUMORSMETASTATIC TUMORS
leptomeningeal carcinomatosisleptomeningeal carcinomatosis
METASTATIC MELANOMAMETASTATIC MELANOMA
PRIMARY CNS LYMPHOMAPRIMARY CNS LYMPHOMA
Summary: Brain tumorsSummary: Brain tumors
 Primary brain tumors: glia (low grade vs. highPrimary brain tumors: glia (low grade vs. high
grade), neurons, meningesgrade), neurons, meninges
 Nerve sheath tumors: schwannoma andNerve sheath tumors: schwannoma and
neurofibromaneurofibroma
 Secondary brain tumors: Metastatic (lung-males,Secondary brain tumors: Metastatic (lung-males,
breast-females, melanoma, renal cell carcinoma)breast-females, melanoma, renal cell carcinoma)
 Tumors arising outside the CNS with CNSTumors arising outside the CNS with CNS
symptoms: pituitary adenoma,symptoms: pituitary adenoma,
craniopharyngiomacraniopharyngioma
DISEASES OF MYELINDISEASES OF MYELIN
AND PERIPHERALAND PERIPHERAL
NERVENERVE
MYELINMYELIN
PNS MYELINPNS MYELIN CNSCNS
MYELINMYELIN
CNS MYELINCNS MYELIN
oligodendrocytesoligodendrocytes
DISEASES OF MYELINDISEASES OF MYELIN
 DEMYELINATING DISEASES:DEMYELINATING DISEASES:
 Acquired disorders of myelin, such as multipleAcquired disorders of myelin, such as multiple
sclerosis.sclerosis.
 DYSMYELINATING DISEASES:DYSMYELINATING DISEASES:
 Genetic disorders of myelin and its turnover,Genetic disorders of myelin and its turnover,
such as leukodystrophiessuch as leukodystrophies
MULTIPLE SCLEROSISMULTIPLE SCLEROSIS
 Multiple sclerosis is the most common diseaseMultiple sclerosis is the most common disease
of CNS myelin; prevalence of 1:1000.of CNS myelin; prevalence of 1:1000.
 Central nervous system myelin is selectivelyCentral nervous system myelin is selectively
destroyed (axons are relatively preserved)destroyed (axons are relatively preserved)
 Onset is frequently in 30 and 40 year old ageOnset is frequently in 30 and 40 year old age
groups.groups.
 The disease is typically progressive with relapsingThe disease is typically progressive with relapsing
and remitting accumulations of focal neurologicand remitting accumulations of focal neurologic
deficits.deficits.
 The etiology is thought to be autoimmune inThe etiology is thought to be autoimmune in
naturenature
MULTIPLE SCLEROSISMULTIPLE SCLEROSIS
PLAQUESPLAQUES
MULTIPLE SCLEROSISMULTIPLE SCLEROSIS
PLAQUEPLAQUE
MULTIPLE SCLEROSISMULTIPLE SCLEROSIS
PLAQUESPLAQUES
optic chiasmoptic chiasm
MULTIPLE SCLEROSISMULTIPLE SCLEROSIS
PLAQUESPLAQUES
PONTINE MS PLAQUEPONTINE MS PLAQUE
adjacent sections for myelin andadjacent sections for myelin and
axonsaxons
 Luxol fast-blue-PASLuxol fast-blue-PAS BielschowskyBielschowsky
MULTIPLE SCLEROSIS PLAQUEMULTIPLE SCLEROSIS PLAQUE
sharp circumscriptionsharp circumscription
ACUTE DISSEMINATEDACUTE DISSEMINATED
ENCEPHALOMYELITISENCEPHALOMYELITIS
 Post- or parainfectious encephalomyelitis:Post- or parainfectious encephalomyelitis:
 following a viral infectionfollowing a viral infection
 Postvaccinial encephalomyelitis:Postvaccinial encephalomyelitis:
 Pasteur rabies and smallpox vaccinationPasteur rabies and smallpox vaccination
 Akin to EAE (experimental allergic enceph.)Akin to EAE (experimental allergic enceph.)
 ADE is an acute, monophasic illnessADE is an acute, monophasic illness
 Pathology:Pathology:
 Perivenous lymphocytic infiltrates withPerivenous lymphocytic infiltrates with
demyelinationdemyelination
 Autoimmune mechanismAutoimmune mechanism
ACUTE DISSEMINATEDACUTE DISSEMINATED
ENCEPHALOMYELITISENCEPHALOMYELITIS
(ADEM)(ADEM)
H & EH & E Myelin basicMyelin basic
protein IHCprotein IHC
ACUTE DISSEMINATEDACUTE DISSEMINATED
ENCEPHALOMYELITISENCEPHALOMYELITIS
(ADEM)(ADEM)
Myasthenia GravisMyasthenia Gravis
 An autoimmune neuromuscular disease that resultsAn autoimmune neuromuscular disease that results
from autoantibodies at the neuromuscular junction.from autoantibodies at the neuromuscular junction.
 Characterized by variable weakness of voluntary muscles (eyeCharacterized by variable weakness of voluntary muscles (eye
muscles may be weak)muscles may be weak)
 Worsens with activity (and late in the day)Worsens with activity (and late in the day)
 May be associated with other autoimmune disordersMay be associated with other autoimmune disorders
such as thyroid disease, rheumatoid arthritis and SLEsuch as thyroid disease, rheumatoid arthritis and SLE
 Often associated with a thymoma, removal of theOften associated with a thymoma, removal of the
thymoma may be curative.thymoma may be curative.
LEUKODYSTROPHIESLEUKODYSTROPHIES
 CLINICAL: A variety of inherited diseases withCLINICAL: A variety of inherited diseases with
variable age of onset (usually in childhood) andvariable age of onset (usually in childhood) and
rate of progression, which typically result inrate of progression, which typically result in
diffuse severe dysfunction.diffuse severe dysfunction.
 PATHOGENESIS:PATHOGENESIS: Recessive mutations inRecessive mutations in
proteins related to myelin structure orproteins related to myelin structure or
metabolismmetabolism
 The peripheral nervous system also may beThe peripheral nervous system also may be
involved in a number of formsinvolved in a number of forms
PATHOLOGY OFPATHOLOGY OF
LEUKODYSTROPHIESLEUKODYSTROPHIES
 Demyelination in large confluent foci within the cerebralDemyelination in large confluent foci within the cerebral
hemispheres and other siteshemispheres and other sites
 GENERAL:GENERAL:
1.1. Loss of myelin and oligodendrogliaLoss of myelin and oligodendroglia
2.2. Relative preservation of axonsRelative preservation of axons
 DISEASE SPECIFIC:DISEASE SPECIFIC:
1.1. Globoid cells (Krabbe’s disease)Globoid cells (Krabbe’s disease)
2.2. Metachromatic material in macrophages and neuronsMetachromatic material in macrophages and neurons
(metachromatic leukodystrophy, aryl sulfatase deficient)(metachromatic leukodystrophy, aryl sulfatase deficient)
3.3. Adrenal atrophy and cytosomal inclusions (ALD,Adrenal atrophy and cytosomal inclusions (ALD,
peroxisomal abnormality)peroxisomal abnormality)
METACHROMATICMETACHROMATIC
LEUKODYSTROPHYLEUKODYSTROPHY
METACHROMATICMETACHROMATIC
LEUKODYSTROPHYLEUKODYSTROPHY
sparing of subcortical arcuate fiberssparing of subcortical arcuate fibers
METACHROMATICMETACHROMATIC
LEUKODYSTROPHYLEUKODYSTROPHY
(aryl sulfatase deficiency)(aryl sulfatase deficiency)
Acidified cresyl violetAcidified cresyl violet LFB-PASLFB-PAS
metachromasiametachromasia
ADRENOLEUKODYSTROPHYADRENOLEUKODYSTROPHY
ADRENOLEUKODYSTROPHYADRENOLEUKODYSTROPHY
lymphocytic infiltrateslymphocytic infiltrates
KRABBE’S DISEASEKRABBE’S DISEASE
(GLOBOID CELL(GLOBOID CELL
LEUKODYSTROPHY)LEUKODYSTROPHY)
cerebroside-cerebroside-ββ-galactosidase deficiency-galactosidase deficiency
DISEASES OF PERIPHERALDISEASES OF PERIPHERAL
NERVENERVE
CLASSIFICATION BY PATHOLOGYCLASSIFICATION BY PATHOLOGY
Demyelinating neuropathiesDemyelinating neuropathies
Guillain-Barre-Landry syndromeGuillain-Barre-Landry syndrome
Chronic inflammatory demyelinating polyneuropathyChronic inflammatory demyelinating polyneuropathy
(CIDP)(CIDP)
Axonal neuropathies: most neuropathies areAxonal neuropathies: most neuropathies are
axonal but pathology often is nonspecificaxonal but pathology often is nonspecific
Examples include hypertrophic neuropathies,Examples include hypertrophic neuropathies,
herpes zoster, HIV, alcoholic and diabeticherpes zoster, HIV, alcoholic and diabetic
neuropathiesneuropathies
DEMYELINATING NEUROPATHYDEMYELINATING NEUROPATHY
GUILLAIN-BARRE-LANDRYGUILLAIN-BARRE-LANDRY
LFB-PASLFB-PAS Silver stainSilver stain
DEMYELINATING NEUROPATHYDEMYELINATING NEUROPATHY
GUILLAIN-BARRE-LANDRYGUILLAIN-BARRE-LANDRY
inflammatory demyelinationinflammatory demyelination
DEMYELINATINGDEMYELINATING
NEUROPATHYNEUROPATHY
GUILLAIN-BARRE-LANDRYGUILLAIN-BARRE-LANDRY
evidence of remyelinationevidence of remyelination
Summary:Summary:
Demyelinating/DysmyelinatingDemyelinating/Dysmyelinating
diseasesdiseases
 Demyelinating disease: most common is MS,Demyelinating disease: most common is MS,
acute disseminated encephalomyelitis (rare,acute disseminated encephalomyelitis (rare,
follows viral infection, vaccination)follows viral infection, vaccination)
 Leukodystrophies: Genetic diseases (manyLeukodystrophies: Genetic diseases (many
enzyme abnormalities are defined) resulting inenzyme abnormalities are defined) resulting in
myelin loss, occur early in life.myelin loss, occur early in life.
 Peripheral nerve demyelination: Guillain-BarrePeripheral nerve demyelination: Guillain-Barre
Syndrome, autoimmune, potential forSyndrome, autoimmune, potential for
remyelination with complete recoveryremyelination with complete recovery
NeurodegenerativeNeurodegenerative
diseasesdiseases
Dementia:Dementia:
Alzheimer’s disease, Pick’s diseaseAlzheimer’s disease, Pick’s disease
Movement Disorders:Movement Disorders:
Parkinson’s disease, Huntington’sParkinson’s disease, Huntington’s
disease, Multiple Systems Atrophydisease, Multiple Systems Atrophy
Motor Disease:Motor Disease:
ALS, Werdnig-Hoffman, PoliomyelitisALS, Werdnig-Hoffman, Poliomyelitis
Prion diseasePrion disease
Alzheimer’s disease: ClinicalAlzheimer’s disease: Clinical
featuresfeatures
 Clinical features of dementiaClinical features of dementia
 Impairment of recent memoryImpairment of recent memory
 Aphasia (naming), apraxia (motor), agnosiaAphasia (naming), apraxia (motor), agnosia
(object), executive functioning(object), executive functioning
 Impaired level of functionImpaired level of function
 Progressive over timeProgressive over time
 47% of people over 85 years of age are47% of people over 85 years of age are
affectedaffected
Alzheimer’s disease: PathogenesisAlzheimer’s disease: Pathogenesis
 The amyloid hypothesis:The amyloid hypothesis:
Abnormal APP processingAbnormal APP processing
leads to deposits ofleads to deposits of
insoluble B-pleatedinsoluble B-pleated
amyloid proteinamyloid protein
Alzheimer’s disease: Gross andAlzheimer’s disease: Gross and
microscopic featuresmicroscopic features
 Gross brain atrophy: neuronal lossGross brain atrophy: neuronal loss
 Neuritic (senile) plaquesNeuritic (senile) plaques containingcontaining B-B-
amyloidamyloid
 Neurofibrillary tanglesNeurofibrillary tangles composed ofcomposed of
phosphorylated microtubule associatedphosphorylated microtubule associated tautau
proteinprotein
 Cerebral amyloidosisCerebral amyloidosis
Other DementiasOther Dementias
 Dementia with Lewy bodiesDementia with Lewy bodies
 Second most common neurodegenerative cause ofSecond most common neurodegenerative cause of
dementiadementia
 Lewy bodies and neurodegeneration affect brainstemLewy bodies and neurodegeneration affect brainstem
and cortexand cortex
 Pick’s disease and other frontal temporalPick’s disease and other frontal temporal
dementiasdementias
 Classification depends on histologic examination andClassification depends on histologic examination and
is complicatedis complicated
Parkinson’s disease: ClinicalParkinson’s disease: Clinical
findingsfindings
 Idiopathic Parkinson’s disease (vs.Idiopathic Parkinson’s disease (vs.
parkinsonism or parkinsonian syndrome),parkinsonism or parkinsonian syndrome),
est 1% of population over 50 years of ageest 1% of population over 50 years of age
 TremorTremor (rest)(rest)
 RigidityRigidity (cogwheel rigidity)(cogwheel rigidity)
 BradykinesiaBradykinesia (mask-like facies, loss of arm-(mask-like facies, loss of arm-
swing)swing)
 Festinating gait (loss of righting reflexes)Festinating gait (loss of righting reflexes)
Parkinson’s disease: Gross andParkinson’s disease: Gross and
microscopic findingsmicroscopic findings
 Gross--Gross--loss of pigmentloss of pigment in thein the substantiasubstantia
nigranigra
 Microscopic--Lewy bodies with pigmentedMicroscopic--Lewy bodies with pigmented
neuronal cell loss and gliosisneuronal cell loss and gliosis
 cortical Lewy bodies present in 80% or morecortical Lewy bodies present in 80% or more
of PD casesof PD cases
Parkinson’s Disease
Other Extrapyramidal MovementOther Extrapyramidal Movement
DisordersDisorders
 Parkinson’s disease: HypokineticParkinson’s disease: Hypokinetic
 Huntington’s disease: HyperkineticHuntington’s disease: Hyperkinetic
 Choreiform movementsChoreiform movements
 Intellectual declineIntellectual decline
 Multiple Systems AtrophyMultiple Systems Atrophy
 Parkinsonian featuresParkinsonian features
 Symptoms suggestive of olivopontocerebellarSymptoms suggestive of olivopontocerebellar
degenerationdegeneration
 Shy-Drager syndrome (parasympathetic dysfunction)Shy-Drager syndrome (parasympathetic dysfunction)
Motor neuron diseaseMotor neuron disease
 Amyotrophic lateral sclerosis (Lou Gehrig’sAmyotrophic lateral sclerosis (Lou Gehrig’s
disease)disease)
 Results in progressive weakness, eventually resultingResults in progressive weakness, eventually resulting
in paralysis of respiratory muscles and death oftenin paralysis of respiratory muscles and death often
within 2-5 years of diagnosiswithin 2-5 years of diagnosis
 Degeneration of upper (motor cortex) and lowerDegeneration of upper (motor cortex) and lower
(spinal cord) motor neurons(spinal cord) motor neurons
Motor Neuron DiseaseMotor Neuron Disease
 ALS: Adult form of motor neuron diseaseALS: Adult form of motor neuron disease
associated with both upper (brain) and lowerassociated with both upper (brain) and lower
(spinal cord) motor involvement(spinal cord) motor involvement
 Werdnig-Hoffman disease: The baby is weakWerdnig-Hoffman disease: The baby is weak
(floppy) at birth. Lower (spinal cord) motor(floppy) at birth. Lower (spinal cord) motor
neurons are involved.neurons are involved.
 Poliomyelitis: Lower motor neurons arePoliomyelitis: Lower motor neurons are
destroyed.destroyed.
Prion disease (SpongiformPrion disease (Spongiform
encephalopathy): Clinical findingsencephalopathy): Clinical findings
 50-70 years old,50-70 years old, rapidly evolving dementiarapidly evolving dementia,,
often withoften with myoclonusmyoclonus and a characteristic EEGand a characteristic EEG
pattern (of repetitive sharp waves)pattern (of repetitive sharp waves)
 Early symptoms include personality changes,Early symptoms include personality changes,
impaired judgement, gait abnormalities, vertigo,impaired judgement, gait abnormalities, vertigo,
 In some patients cerebellar and visualIn some patients cerebellar and visual
abnormalities predominateabnormalities predominate
 MajorityMajority die w/in 6 monthsdie w/in 6 months, frequently w/in 3, frequently w/in 3
mo.mo.
Prion disease: PathogenesisPrion disease: Pathogenesis
 Transmissible but not “infectious”Transmissible but not “infectious”
 Prion proteinPrion protein, Prusiner--1997 Nobel Prize, (not a, Prusiner--1997 Nobel Prize, (not a
“slow virus”)“slow virus”)
 PrPPrPCC
-- produced normally in most cells --amino acid-- produced normally in most cells --amino acid
sequence is identical to the PrPsequence is identical to the PrPSCSC
--abnormal protein, the--abnormal protein, the
difference is in the secondary conformation (B-pleateddifference is in the secondary conformation (B-pleated
vs alpha helical) PrPvs alpha helical) PrPSCSC
causes post-translationalcauses post-translational
modification of PrPmodification of PrPCC
 Transmitted by direct inoculation (corneal transplants,Transmitted by direct inoculation (corneal transplants,
dural grafts, pituitary products)dural grafts, pituitary products)
Prion disease: Gross andPrion disease: Gross and
microscopic findingsmicroscopic findings
 Gross appearance--may be normal due toGross appearance--may be normal due to
short duration of diseaseshort duration of disease
 Microscopic appearance--vacuolation ofMicroscopic appearance--vacuolation of
neuropil, vacuoles are within nerve cellneuropil, vacuoles are within nerve cell
bodies and neuronal processesbodies and neuronal processes
 cell loss and gliosis may be prominentcell loss and gliosis may be prominent
Prion Disease
Summary: NeurodegenerativeSummary: Neurodegenerative
diseasesdiseases
 DementiaDementia
 Alzheimer’s disease: common, amyloid hypothesis, plaquesAlzheimer’s disease: common, amyloid hypothesis, plaques
and tangles, gross brain atrophyand tangles, gross brain atrophy
 Prion disease: rare, “transmissible” protein, rapidlyPrion disease: rare, “transmissible” protein, rapidly
progressive, vacuolar changesprogressive, vacuolar changes
 Movement disordersMovement disorders
 Parkinson’s disease: hypokinetic, loss of dopaminergic cellsParkinson’s disease: hypokinetic, loss of dopaminergic cells
substantia nigra, Lewy bodiessubstantia nigra, Lewy bodies
 Huntington’s disease: choreiform movements, caudateHuntington’s disease: choreiform movements, caudate
atrophy, nuclear inclusionsatrophy, nuclear inclusions
 Motor neuron disease (ALS): Loss of upper and lowerMotor neuron disease (ALS): Loss of upper and lower
motor neurons, progressive over 2-5 yearsmotor neurons, progressive over 2-5 years
PediatricPediatric
NeuropathologyNeuropathology
Developmental AbnormalitiesDevelopmental Abnormalities
Neuronal Storage DiseasesNeuronal Storage Diseases
Familial Tumor SyndromesFamilial Tumor Syndromes
Perinatal Lesions/InfectionsPerinatal Lesions/Infections
Trauma: shaken baby syndromeTrauma: shaken baby syndrome
Developmental Abnormalities:Developmental Abnormalities:
PathologyPathology
 Organ inductionOrgan induction (2.5-6 weeks): neural tube defects:(2.5-6 weeks): neural tube defects:
anencephaly, spinal dysraphism, encephalocele,anencephaly, spinal dysraphism, encephalocele,
holoprosencephalyholoprosencephaly
 Neuronal (glial) migrationNeuronal (glial) migration (3-6 months):(3-6 months):
lissencephaly, microcephaly, polymicrogyria, agenesis oflissencephaly, microcephaly, polymicrogyria, agenesis of
the corpus callosumthe corpus callosum
 MyelinationMyelination (2 months-juvenile)(2 months-juvenile)
 SynaptogenesisSynaptogenesis (20 week gestation-adulthood):(20 week gestation-adulthood):
trisomy 21, fragile X, cretinismtrisomy 21, fragile X, cretinism
In general,In general, earlier insults cause more severe structuralearlier insults cause more severe structural
damagedamage
Organ Induction:Organ Induction:
Dysraphic DisordersDysraphic Disorders
 Failure of neural tube folds to close duringFailure of neural tube folds to close during
developmentdevelopment
 Prenatal testing may reveal an elevated maternal serumPrenatal testing may reveal an elevated maternal serum
AFPAFP
 Folate deficiency: Folic acid supplementation prior toFolate deficiency: Folic acid supplementation prior to
conception may reduce the incidence of neural tubeconception may reduce the incidence of neural tube
defects up to 70%defects up to 70%
 Neural tube defects range from small bony defects in theNeural tube defects range from small bony defects in the
lumbosacral region (spina bifida occulta) tolumbosacral region (spina bifida occulta) to
craniorachischisis.craniorachischisis.
 Myelomeningoceles occur most commonly in theMyelomeningoceles occur most commonly in the
lumbosacral regionlumbosacral region
Neuronal migration disordersNeuronal migration disorders
 Lissencephaly (smooth brain)/pachygyria (fewLissencephaly (smooth brain)/pachygyria (few
enlarged gyrienlarged gyri
 Polymicrogyria (many small gyri)Polymicrogyria (many small gyri)
 Heterotopias (circumscribed collections) andHeterotopias (circumscribed collections) and
dysplasias (disorganized lamination)dysplasias (disorganized lamination)
 Occur with other developmental abnormalities forOccur with other developmental abnormalities for
example in patients with chromosomal abnormalitiesexample in patients with chromosomal abnormalities
 May be the focus of seizure activityMay be the focus of seizure activity
SeizuresSeizures
 Result from abnormal electrical activity of a group ofResult from abnormal electrical activity of a group of
brain cells and cause an altered mental state or tonicbrain cells and cause an altered mental state or tonic
clonic movements. May be partial (focal) orclonic movements. May be partial (focal) or
generalized.generalized.
 In children seizures may result from neuronal migrationIn children seizures may result from neuronal migration
abnormalities or from abnormalities acquiredabnormalities or from abnormalities acquired
subsequent to brain damage (such as inflammation)subsequent to brain damage (such as inflammation)
 A first time seizure in an adult would warrant anA first time seizure in an adult would warrant an
imaging study to rule out tumor or other structuralimaging study to rule out tumor or other structural
abnormalityabnormality
Neuronal Storage DiseaseNeuronal Storage Disease
 Result from inborn errors of metabolism (deficientResult from inborn errors of metabolism (deficient
enzyme or abnormal lysosomal function)enzyme or abnormal lysosomal function)
 Progressive, poor treatment options (bone marrowProgressive, poor treatment options (bone marrow
transplant)transplant)
 Accumulation of metabolic products in the neuronAccumulation of metabolic products in the neuron
 Tay Sachs diseaseTay Sachs disease
 Neuronal ceroid lipofuscinosisNeuronal ceroid lipofuscinosis
 Glycogen storage diseaseGlycogen storage disease
Concentric Multilamellar membranous cytoplasmic bodies (MCB’s)
Familial Tumor SyndromesFamilial Tumor Syndromes
 NeurofibromatosisNeurofibromatosis
 NF-1: (most common) multiple peripheral neurofibromasNF-1: (most common) multiple peripheral neurofibromas
 NF-2: bilateral acoustic schwannomas and meningiomasNF-2: bilateral acoustic schwannomas and meningiomas
 Tuberous Sclerosis: subcortical and corticalTuberous Sclerosis: subcortical and cortical
hamaratomas(tubers)hamaratomas(tubers)
-Autosomal dominant-Autosomal dominant
-Tumor suppressor gene mutations-Tumor suppressor gene mutations
-Cutaneous findings-Cutaneous findings
Perinatal Lesions ofPerinatal Lesions of
the CNSthe CNS
HemorrhageHemorrhage
Hypoxic/IschemicHypoxic/Ischemic
InfectiousInfectious
Congenital/Perinatal InfectionsCongenital/Perinatal Infections
TORCHTORCH
 ToxoplasmosisToxoplasmosis
 Other: syphilis, TB, listeria monocytogenes;Other: syphilis, TB, listeria monocytogenes;
other viruses (VZV, HepB)other viruses (VZV, HepB)
 Rubella (rare—immunizations)Rubella (rare—immunizations)
 Cytomegalovirus, Chlamydia trachomatisCytomegalovirus, Chlamydia trachomatis
 Herpes simplex (usually type 2); HIVHerpes simplex (usually type 2); HIV
Shaken Baby SyndromeShaken Baby Syndrome
 General: Violent shaking causes accelerationGeneral: Violent shaking causes acceleration
((shearingshearing) injury of axons:) injury of axons: diffuse axonal injurydiffuse axonal injury
 Neurologic: Blindness/mental retardation in infantsNeurologic: Blindness/mental retardation in infants
less than 1 year of age. Present with apnea, seizures,less than 1 year of age. Present with apnea, seizures,
lethargy, bradycardia, respiratory difficulty, coma.lethargy, bradycardia, respiratory difficulty, coma.
 Pathology:Pathology: Oculo-cerebral damage can occurOculo-cerebral damage can occur
without external evidence of head injury.without external evidence of head injury. RetinalRetinal
and optic nerve sheath hemorrhage—and optic nerve sheath hemorrhage—
ophthalmoscopic exam importantophthalmoscopic exam important
 Microscopic: Axonal spheroidsMicroscopic: Axonal spheroids
Summary: Pediatric neuropathologySummary: Pediatric neuropathology
 Developmental abnormalities: Neural tubeDevelopmental abnormalities: Neural tube
defects (anencephaly, spina bifida), migrationaldefects (anencephaly, spina bifida), migrational
defects (mental retardation, seizures)defects (mental retardation, seizures)
 Inborn errors of metabolism: Neuronal storageInborn errors of metabolism: Neuronal storage
diseases and leukodystrophiesdiseases and leukodystrophies
 Other: Familial tumor syndromes, hemorrhage,Other: Familial tumor syndromes, hemorrhage,
hypoxic/ischemic injury, shaken baby syndromehypoxic/ischemic injury, shaken baby syndrome
Pathology of the Nervous SystemPathology of the Nervous System
 IntroductionIntroduction
 IncreasedIncreased
intracranialintracranial
pressurepressure
 Vascular andVascular and
circulatorycirculatory
disordersdisorders
 TraumaTrauma
 InfectionsInfections
 TumorsTumors
 DemyelinatingDemyelinating
diseasesdiseases
 DegenerativeDegenerative
diseasesdiseases
 DevelopmentalDevelopmental
AbnormalitiesAbnormalities
The more people IThe more people I
meet…meet…
The more I likeThe more I like
my dogmy dog

More Related Content

What's hot

Paraneoplastic syndromes
Paraneoplastic syndromesParaneoplastic syndromes
Paraneoplastic syndromes
SCGH ED CME
 
The cardiovascular system part 1
The cardiovascular system part 1The cardiovascular system part 1
The cardiovascular system part 1
Dr. Varughese George
 
8679901 central-nervous-system-pathology
8679901 central-nervous-system-pathology8679901 central-nervous-system-pathology
8679901 central-nervous-system-pathologyNgaire Taylor
 
Pathology of the male reproductive system 2
Pathology of the male reproductive system 2Pathology of the male reproductive system 2
Pathology of the male reproductive system 2
Chapima Fabian
 
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.pptLESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
mdaquib14
 
Hemodynamic disturbance
Hemodynamic disturbanceHemodynamic disturbance
Hemodynamic disturbanceNguyen Khue
 
Pathology+of+cerebrovascular+disease+dr+anim
Pathology+of+cerebrovascular+disease+dr+animPathology+of+cerebrovascular+disease+dr+anim
Pathology+of+cerebrovascular+disease+dr+animshabeel pn
 
Blood vessel pathology
Blood vessel pathologyBlood vessel pathology
Blood vessel pathology
Gopi sankar
 
Pathology cptr5-genetics
Pathology   cptr5-geneticsPathology   cptr5-genetics
Pathology cptr5-geneticsMBBS IMS MSU
 
Cns response to injury
 Cns response to injury Cns response to injury
Cns response to injury
imrana tanvir
 
LIVER & GALLBLADDER PATHOLOGY
LIVER & GALLBLADDER PATHOLOGYLIVER & GALLBLADDER PATHOLOGY
LIVER & GALLBLADDER PATHOLOGY
Dr. Roopam Jain
 
Haemodynamic disorders , thromboembolism and shock by Dr Nadeem (RMC)
Haemodynamic disorders , thromboembolism and shock by Dr Nadeem (RMC)Haemodynamic disorders , thromboembolism and shock by Dr Nadeem (RMC)
Haemodynamic disorders , thromboembolism and shock by Dr Nadeem (RMC)
Hassan Ahmad
 
Pathology of reactivity
Pathology of reactivity Pathology of reactivity
Pathology of reactivity
MULLAPUDI RAMAKRISHNA
 
Foramen Magnum Meningioma
Foramen Magnum MeningiomaForamen Magnum Meningioma
Foramen Magnum Meningioma
suresh Bishokarma
 
Cardiovascular Pathology (part 1)
Cardiovascular Pathology (part 1)Cardiovascular Pathology (part 1)
Cardiovascular Pathology (part 1)
Louie Ray
 
Hemodynamic disorders
Hemodynamic disordersHemodynamic disorders
Hemodynamic disorders
Ahmed Al-Dawoodi
 
Meningioma of brain
Meningioma of brainMeningioma of brain
Meningioma of brain
suresh Bishokarma
 
Lec 24 24 female reproductive system pathology
Lec 24 24 female reproductive system pathologyLec 24 24 female reproductive system pathology
Lec 24 24 female reproductive system pathology
imrana tanvir
 

What's hot (20)

Paraneoplastic syndromes
Paraneoplastic syndromesParaneoplastic syndromes
Paraneoplastic syndromes
 
8
88
8
 
The cardiovascular system part 1
The cardiovascular system part 1The cardiovascular system part 1
The cardiovascular system part 1
 
8679901 central-nervous-system-pathology
8679901 central-nervous-system-pathology8679901 central-nervous-system-pathology
8679901 central-nervous-system-pathology
 
Pathology of the male reproductive system 2
Pathology of the male reproductive system 2Pathology of the male reproductive system 2
Pathology of the male reproductive system 2
 
Cns tumors
Cns tumorsCns tumors
Cns tumors
 
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.pptLESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
 
Hemodynamic disturbance
Hemodynamic disturbanceHemodynamic disturbance
Hemodynamic disturbance
 
Pathology+of+cerebrovascular+disease+dr+anim
Pathology+of+cerebrovascular+disease+dr+animPathology+of+cerebrovascular+disease+dr+anim
Pathology+of+cerebrovascular+disease+dr+anim
 
Blood vessel pathology
Blood vessel pathologyBlood vessel pathology
Blood vessel pathology
 
Pathology cptr5-genetics
Pathology   cptr5-geneticsPathology   cptr5-genetics
Pathology cptr5-genetics
 
Cns response to injury
 Cns response to injury Cns response to injury
Cns response to injury
 
LIVER & GALLBLADDER PATHOLOGY
LIVER & GALLBLADDER PATHOLOGYLIVER & GALLBLADDER PATHOLOGY
LIVER & GALLBLADDER PATHOLOGY
 
Haemodynamic disorders , thromboembolism and shock by Dr Nadeem (RMC)
Haemodynamic disorders , thromboembolism and shock by Dr Nadeem (RMC)Haemodynamic disorders , thromboembolism and shock by Dr Nadeem (RMC)
Haemodynamic disorders , thromboembolism and shock by Dr Nadeem (RMC)
 
Pathology of reactivity
Pathology of reactivity Pathology of reactivity
Pathology of reactivity
 
Foramen Magnum Meningioma
Foramen Magnum MeningiomaForamen Magnum Meningioma
Foramen Magnum Meningioma
 
Cardiovascular Pathology (part 1)
Cardiovascular Pathology (part 1)Cardiovascular Pathology (part 1)
Cardiovascular Pathology (part 1)
 
Hemodynamic disorders
Hemodynamic disordersHemodynamic disorders
Hemodynamic disorders
 
Meningioma of brain
Meningioma of brainMeningioma of brain
Meningioma of brain
 
Lec 24 24 female reproductive system pathology
Lec 24 24 female reproductive system pathologyLec 24 24 female reproductive system pathology
Lec 24 24 female reproductive system pathology
 

Viewers also liked

Diseases of nervous system patho lab pics
Diseases of nervous system patho lab picsDiseases of nervous system patho lab pics
Diseases of nervous system patho lab picsMD Specialclass
 
Central nervous system pathology lab
Central nervous system pathology labCentral nervous system pathology lab
Central nervous system pathology lab
Mohammad Ihmeidan
 
Nervous System Diseases
Nervous System DiseasesNervous System Diseases
Nervous System Diseases
kevinyocum4
 
The central nervous system ii
The central nervous system iiThe central nervous system ii
The central nervous system iiraj kumar
 
Mental health ppt.
Mental health ppt.Mental health ppt.
Mental health ppt.gusto80
 
Nervous System
Nervous SystemNervous System
Nervous Systemitutor
 
Understanding Mental Health and Mental Illness
Understanding Mental Health and Mental IllnessUnderstanding Mental Health and Mental Illness
Understanding Mental Health and Mental IllnessTeenMentalHealth.org
 
Models of mental health & illness
Models of mental health & illnessModels of mental health & illness
Models of mental health & illness
Sudarshana Dasgupta
 
Disorder of the nervous system
Disorder of the nervous systemDisorder of the nervous system
Disorder of the nervous system
Ofhel Del Mundo
 

Viewers also liked (10)

Diseases of nervous system patho lab pics
Diseases of nervous system patho lab picsDiseases of nervous system patho lab pics
Diseases of nervous system patho lab pics
 
Central nervous system pathology lab
Central nervous system pathology labCentral nervous system pathology lab
Central nervous system pathology lab
 
Nervous System Diseases
Nervous System DiseasesNervous System Diseases
Nervous System Diseases
 
Diseases of nervous system
Diseases of nervous system Diseases of nervous system
Diseases of nervous system
 
The central nervous system ii
The central nervous system iiThe central nervous system ii
The central nervous system ii
 
Mental health ppt.
Mental health ppt.Mental health ppt.
Mental health ppt.
 
Nervous System
Nervous SystemNervous System
Nervous System
 
Understanding Mental Health and Mental Illness
Understanding Mental Health and Mental IllnessUnderstanding Mental Health and Mental Illness
Understanding Mental Health and Mental Illness
 
Models of mental health & illness
Models of mental health & illnessModels of mental health & illness
Models of mental health & illness
 
Disorder of the nervous system
Disorder of the nervous systemDisorder of the nervous system
Disorder of the nervous system
 

Similar to Cns

CT Imaging of Cerebral Ischemia and Infarction
CT Imaging of Cerebral Ischemia and Infarction CT Imaging of Cerebral Ischemia and Infarction
CT Imaging of Cerebral Ischemia and Infarction
Sakher Alkhaderi
 
SUB-Arachnoid Haemorrhage.pdf
SUB-Arachnoid Haemorrhage.pdfSUB-Arachnoid Haemorrhage.pdf
SUB-Arachnoid Haemorrhage.pdf
Shapi. MD
 
Copy Of Cva(3)
Copy Of Cva(3)Copy Of Cva(3)
Copy Of Cva(3)
jomijosephe
 
Cerebral Ischemia
Cerebral IschemiaCerebral Ischemia
Cerebral Ischemia
Xiu Srithammasit
 
Stroke ppt
Stroke pptStroke ppt
strokeppt-170720174010.pdf
strokeppt-170720174010.pdfstrokeppt-170720174010.pdf
strokeppt-170720174010.pdf
RiyaSharma295
 
Cerebrovascular diseases.pptx
Cerebrovascular diseases.pptxCerebrovascular diseases.pptx
Cerebrovascular diseases.pptx
tesa10
 
CEREBRO VASCULAR DISEASE
CEREBRO VASCULAR DISEASECEREBRO VASCULAR DISEASE
CEREBRO VASCULAR DISEASE
DANIEL VENKATESH (VENKATESAN) ANNAMALAI
 
Stroke
StrokeStroke
Cva5 cerebralvascularaccident
Cva5 cerebralvascularaccidentCva5 cerebralvascularaccident
Cva5 cerebralvascularaccident
G D P A CHOWDARY
 
11.Vascular pathology
11.Vascular pathology11.Vascular pathology
11.Vascular pathology
PNK SINGH
 
Neuro Critical Care
Neuro Critical CareNeuro Critical Care
Neuro Critical Care
James A Gensch
 
Birth injuries
Birth injuriesBirth injuries
Birth injuries
vinay nandimalla
 
an overview of Stroke a cardiovascular accident ( a neurological condition)
an overview of Stroke a cardiovascular accident ( a neurological condition) an overview of Stroke a cardiovascular accident ( a neurological condition)
an overview of Stroke a cardiovascular accident ( a neurological condition)
GurpreetBhogal
 
Imaging in stroke
Imaging in stroke Imaging in stroke
Imaging in stroke
Deepak Garg
 
intracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptx
intracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptxintracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptx
intracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptx
HASSENZAINABUKEMISA
 
stroke
strokestroke
Cerebro vascular lesions
Cerebro vascular lesionsCerebro vascular lesions
Cerebro vascular lesionsAbdellah Nazeer
 
Hydrocephalus presentation
Hydrocephalus presentationHydrocephalus presentation
Hydrocephalus presentation
Hussain Karimi
 

Similar to Cns (20)

CT Imaging of Cerebral Ischemia and Infarction
CT Imaging of Cerebral Ischemia and Infarction CT Imaging of Cerebral Ischemia and Infarction
CT Imaging of Cerebral Ischemia and Infarction
 
SUB-Arachnoid Haemorrhage.pdf
SUB-Arachnoid Haemorrhage.pdfSUB-Arachnoid Haemorrhage.pdf
SUB-Arachnoid Haemorrhage.pdf
 
Copy Of Cva(3)
Copy Of Cva(3)Copy Of Cva(3)
Copy Of Cva(3)
 
Cerebral Ischemia
Cerebral IschemiaCerebral Ischemia
Cerebral Ischemia
 
Stroke ppt
Stroke pptStroke ppt
Stroke ppt
 
strokeppt-170720174010.pdf
strokeppt-170720174010.pdfstrokeppt-170720174010.pdf
strokeppt-170720174010.pdf
 
Cerebrovascular diseases.pptx
Cerebrovascular diseases.pptxCerebrovascular diseases.pptx
Cerebrovascular diseases.pptx
 
CEREBRO VASCULAR DISEASE
CEREBRO VASCULAR DISEASECEREBRO VASCULAR DISEASE
CEREBRO VASCULAR DISEASE
 
Stroke
StrokeStroke
Stroke
 
Cva 09
Cva 09Cva 09
Cva 09
 
Cva5 cerebralvascularaccident
Cva5 cerebralvascularaccidentCva5 cerebralvascularaccident
Cva5 cerebralvascularaccident
 
11.Vascular pathology
11.Vascular pathology11.Vascular pathology
11.Vascular pathology
 
Neuro Critical Care
Neuro Critical CareNeuro Critical Care
Neuro Critical Care
 
Birth injuries
Birth injuriesBirth injuries
Birth injuries
 
an overview of Stroke a cardiovascular accident ( a neurological condition)
an overview of Stroke a cardiovascular accident ( a neurological condition) an overview of Stroke a cardiovascular accident ( a neurological condition)
an overview of Stroke a cardiovascular accident ( a neurological condition)
 
Imaging in stroke
Imaging in stroke Imaging in stroke
Imaging in stroke
 
intracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptx
intracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptxintracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptx
intracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptx
 
stroke
strokestroke
stroke
 
Cerebro vascular lesions
Cerebro vascular lesionsCerebro vascular lesions
Cerebro vascular lesions
 
Hydrocephalus presentation
Hydrocephalus presentationHydrocephalus presentation
Hydrocephalus presentation
 

More from Ajaindu Shrivastava

презентация Vagus
презентация Vagusпрезентация Vagus
презентация Vagus
Ajaindu Shrivastava
 
презентация Trygemini
презентация Trygeminiпрезентация Trygemini
презентация Trygemini
Ajaindu Shrivastava
 
презентация Trochlearis
презентация Trochlearisпрезентация Trochlearis
презентация Trochlearis
Ajaindu Shrivastava
 
презентация Opticus
презентация Opticusпрезентация Opticus
презентация Opticus
Ajaindu Shrivastava
 
презентация Oculomotor
презентация Oculomotorпрезентация Oculomotor
презентация Oculomotor
Ajaindu Shrivastava
 
презентация Hypoglosus
презентация Hypoglosusпрезентация Hypoglosus
презентация Hypoglosus
Ajaindu Shrivastava
 
презентация Glossofaryngeas
презентация Glossofaryngeasпрезентация Glossofaryngeas
презентация Glossofaryngeas
Ajaindu Shrivastava
 
презентация Facialis
презентация Facialisпрезентация Facialis
презентация Facialis
Ajaindu Shrivastava
 
презентация Accesorius
презентация Accesoriusпрезентация Accesorius
презентация Accesorius
Ajaindu Shrivastava
 
презентация Abducens
презентация Abducensпрезентация Abducens
презентация Abducens
Ajaindu Shrivastava
 
Lecture piramidal system
Lecture piramidal systemLecture piramidal system
Lecture piramidal system
Ajaindu Shrivastava
 
Higher cortex function
Higher cortex functionHigher cortex function
Higher cortex function
Ajaindu Shrivastava
 
Extrapyram system
Extrapyram systemExtrapyram system
Extrapyram system
Ajaindu Shrivastava
 
Ch 15 sensory pathways
Ch 15 sensory pathwaysCh 15 sensory pathways
Ch 15 sensory pathways
Ajaindu Shrivastava
 
Cellebelar
CellebelarCellebelar
Autonomicnervoussystem 091105103703-phpapp02
Autonomicnervoussystem 091105103703-phpapp02Autonomicnervoussystem 091105103703-phpapp02
Autonomicnervoussystem 091105103703-phpapp02
Ajaindu Shrivastava
 
1 sensation and its disorders
1 sensation and its disorders1 sensation and its disorders
1 sensation and its disorders
Ajaindu Shrivastava
 
Physical and psycho motor development of children of different age groups
Physical and psycho motor development of children of different age groupsPhysical and psycho motor development of children of different age groups
Physical and psycho motor development of children of different age groups
Ajaindu Shrivastava
 
App of nervous sys 2015
App of nervous sys 2015App of nervous sys 2015
App of nervous sys 2015
Ajaindu Shrivastava
 
Internal med sem 6 lect 1
Internal med sem 6 lect 1Internal med sem 6 lect 1
Internal med sem 6 lect 1
Ajaindu Shrivastava
 

More from Ajaindu Shrivastava (20)

презентация Vagus
презентация Vagusпрезентация Vagus
презентация Vagus
 
презентация Trygemini
презентация Trygeminiпрезентация Trygemini
презентация Trygemini
 
презентация Trochlearis
презентация Trochlearisпрезентация Trochlearis
презентация Trochlearis
 
презентация Opticus
презентация Opticusпрезентация Opticus
презентация Opticus
 
презентация Oculomotor
презентация Oculomotorпрезентация Oculomotor
презентация Oculomotor
 
презентация Hypoglosus
презентация Hypoglosusпрезентация Hypoglosus
презентация Hypoglosus
 
презентация Glossofaryngeas
презентация Glossofaryngeasпрезентация Glossofaryngeas
презентация Glossofaryngeas
 
презентация Facialis
презентация Facialisпрезентация Facialis
презентация Facialis
 
презентация Accesorius
презентация Accesoriusпрезентация Accesorius
презентация Accesorius
 
презентация Abducens
презентация Abducensпрезентация Abducens
презентация Abducens
 
Lecture piramidal system
Lecture piramidal systemLecture piramidal system
Lecture piramidal system
 
Higher cortex function
Higher cortex functionHigher cortex function
Higher cortex function
 
Extrapyram system
Extrapyram systemExtrapyram system
Extrapyram system
 
Ch 15 sensory pathways
Ch 15 sensory pathwaysCh 15 sensory pathways
Ch 15 sensory pathways
 
Cellebelar
CellebelarCellebelar
Cellebelar
 
Autonomicnervoussystem 091105103703-phpapp02
Autonomicnervoussystem 091105103703-phpapp02Autonomicnervoussystem 091105103703-phpapp02
Autonomicnervoussystem 091105103703-phpapp02
 
1 sensation and its disorders
1 sensation and its disorders1 sensation and its disorders
1 sensation and its disorders
 
Physical and psycho motor development of children of different age groups
Physical and psycho motor development of children of different age groupsPhysical and psycho motor development of children of different age groups
Physical and psycho motor development of children of different age groups
 
App of nervous sys 2015
App of nervous sys 2015App of nervous sys 2015
App of nervous sys 2015
 
Internal med sem 6 lect 1
Internal med sem 6 lect 1Internal med sem 6 lect 1
Internal med sem 6 lect 1
 

Recently uploaded

1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 

Recently uploaded (20)

1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 

Cns

  • 1. Pathology of thePathology of the Nervous SystemNervous System Karen SantaCruz MDKaren SantaCruz MD Brent Clark MD, PhDBrent Clark MD, PhD
  • 2. Pathology of the Nervous SystemPathology of the Nervous System  IntroductionIntroduction  IncreasedIncreased intracranialintracranial pressurepressure  Vascular andVascular and circulatorycirculatory disordersdisorders  TraumaTrauma  InfectionsInfections  TumorsTumors  DemyelinatingDemyelinating diseasesdiseases  DegenerativeDegenerative diseasesdiseases  DevelopmentalDevelopmental AbnormalitiesAbnormalities
  • 3. Hematoxylin and Eosin Luxol fast-blue-PASLuxol fast-blue-PAS BielschowskyBielschowsky
  • 4. Cell typesCell types 1.1. Neuron:Neuron: functions in neural transmission, mostfunctions in neural transmission, most vulnerable cell, limited regenerationvulnerable cell, limited regeneration 2.2. AstrocyteAstrocyte: major reactive cell of CNS forms ‘scar’: major reactive cell of CNS forms ‘scar’ 3.3. OligodendrocyteOligodendrocyte: highly vulnerable, limited: highly vulnerable, limited proliferation, forms myelin sheathproliferation, forms myelin sheath 4.4. Ependymal cellEpendymal cell: vulnerable, limited regeneration,: vulnerable, limited regeneration, lines ventricles (ependymal granulations)lines ventricles (ependymal granulations) 5.5. Microglial cellMicroglial cell: monocyte/macrophage (bone: monocyte/macrophage (bone marrow) derived phagocytic cell, antigenmarrow) derived phagocytic cell, antigen presentation, producer of cytokines,presentation, producer of cytokines, inflammatory cellinflammatory cell
  • 5. IntroductionIntroduction  Cellular reactions of the central nervous systemCellular reactions of the central nervous system  Neurons: permanentNeurons: permanent  Axonal retraction (axonal spheroids)Axonal retraction (axonal spheroids)  Ischemic cell changesIschemic cell changes  Atrophy and degenerationAtrophy and degeneration  Intraneuronal deposits and inclusionsIntraneuronal deposits and inclusions (neurodegenerative diseases)(neurodegenerative diseases)  Glia: proliferate, form glial ‘scar’Glia: proliferate, form glial ‘scar’
  • 10. Mechanisms of dysfunction causingMechanisms of dysfunction causing diseasedisease  Pathophysiological (toxic/metabolic)Pathophysiological (toxic/metabolic)  StructuralStructural Focal lesions correlate with localizing symptomsFocal lesions correlate with localizing symptoms System degenerations correlate with functionallySystem degenerations correlate with functionally localizing symptoms (ie motor neuron disease)localizing symptoms (ie motor neuron disease)  Increased intracranial pressure (generalized orIncreased intracranial pressure (generalized or focal), can cause global symptoms or brainfocal), can cause global symptoms or brain herniation since the volume of the brain is fixed byherniation since the volume of the brain is fixed by the skullthe skull
  • 11. Increased intracranialIncreased intracranial pressurepressure HeadacheHeadache VomitingVomiting Decreased Level of ConsciousnessDecreased Level of Consciousness PapilledemaPapilledema HerniationHerniation
  • 12. Causes of Cerebral EdemaCauses of Cerebral Edema  GeneralizedGeneralized (frequently(frequently cytotoxic)cytotoxic)  HypoxiaHypoxia  ToxinsToxins  EncephalitisEncephalitis  TraumaTrauma  Focal (often vasogenic)Focal (often vasogenic)  InfarctionInfarction  Injury/contusionInjury/contusion  Mass—neoplastic,Mass—neoplastic, infectious (cerebralinfectious (cerebral abscess), hematomaabscess), hematoma
  • 13. TYPES OF HERNIATIONTYPES OF HERNIATION 1.1. SubfalcineSubfalcine (cingulate)(cingulate) 2.2. TranstentorialTranstentorial (uncal)(uncal) 3.3. TonsillarTonsillar (foramen(foramen magnum)magnum) 4.4. ExtracranialExtracranial
  • 14. TRANSTENTORIAL (UNCAL)TRANSTENTORIAL (UNCAL) HERNIATIONHERNIATION SHIFT OF THE BRAIN FROM THE MIDDLE TOSHIFT OF THE BRAIN FROM THE MIDDLE TO THE POSTERIOR FOSSA THROUGH THETHE POSTERIOR FOSSA THROUGH THE TENTORIAL INCISURATENTORIAL INCISURA MAY BE UNILATERAL OR “CENTRAL”MAY BE UNILATERAL OR “CENTRAL” SECONDARY EFFECTS INCLUDE:SECONDARY EFFECTS INCLUDE: Compression of the third cranial nerve(s)Compression of the third cranial nerve(s) Duret hemorrhages in midline rostral brainstemDuret hemorrhages in midline rostral brainstem Compression of the contralateral cerebral peduncleCompression of the contralateral cerebral peduncle (Kernohan’s notch)(Kernohan’s notch) Compression of the posterior cerebral artery withCompression of the posterior cerebral artery with infarction of the medial occipital lobeinfarction of the medial occipital lobe
  • 15. UNCAL HERNIATIONUNCAL HERNIATION Normal uncusNormal uncus Herniated rightHerniated right uncusuncus
  • 16. DURET HEMORRHAGESDURET HEMORRHAGES Midline Duret hemorrhages plus Kernohan’sMidline Duret hemorrhages plus Kernohan’s notch in the right cerebral pedunclenotch in the right cerebral peduncle
  • 17. HYDROCEPHALUSHYDROCEPHALUS DILATATION OF THE VENTRICULARDILATATION OF THE VENTRICULAR SYSTEMSYSTEM NONCOMMUNICATING: Due toNONCOMMUNICATING: Due to obstruction within the ventricular system,obstruction within the ventricular system, e.g., tumor, aqueductal stenosise.g., tumor, aqueductal stenosis COMMUNICATING: Due to obstruction ofCOMMUNICATING: Due to obstruction of CSF flow in the subarachnoid space withCSF flow in the subarachnoid space with decreased reabsorptiondecreased reabsorption
  • 19. COMMUNICATINGCOMMUNICATING HYDROCEPHALUSHYDROCEPHALUS Dilatation of the entire ventricular system including theDilatation of the entire ventricular system including the aqueduct and fourth ventricular foramina. There isaqueduct and fourth ventricular foramina. There is thickening and scarring of the meninges, secondary tothickening and scarring of the meninges, secondary to previous subarachnoid hemorrhageprevious subarachnoid hemorrhage
  • 20. Summary: Microscopic and grossSummary: Microscopic and gross brain abnormalitiesbrain abnormalities  Cell types: Function and proliferative capacityCell types: Function and proliferative capacity  Mechanisms of CNS dysfunction:Mechanisms of CNS dysfunction:  Pathophysiological “invisible” lesions: metabolic, toxicPathophysiological “invisible” lesions: metabolic, toxic  Structural “visible” abnormalities: mass, edema,Structural “visible” abnormalities: mass, edema, hydrocephalus, cytologic abnormalities.hydrocephalus, cytologic abnormalities.  Increased intracranial pressureIncreased intracranial pressure  Causes of cerebral edema: focal and generalizedCauses of cerebral edema: focal and generalized  Types of herniation: cingulate, uncal, tonsillarTypes of herniation: cingulate, uncal, tonsillar  Hydrocephalus: non-communicating and communicatingHydrocephalus: non-communicating and communicating
  • 21. Vascular andVascular and Circulatory DisordersCirculatory Disorders Ischemia/InfarctionIschemia/Infarction Transient Ischemic AttacksTransient Ischemic Attacks HemorrhageHemorrhage
  • 22. Stroke: Ischemia/InfarctStroke: Ischemia/Infarct  Atherosclerosis: NarrowingAtherosclerosis: Narrowing  Thrombosis: Damages vessel, infarcts areThrombosis: Damages vessel, infarcts are non-hemorrhagicnon-hemorrhagic  Embolism: Heart valves, plaquesEmbolism: Heart valves, plaques (frequently hemorrhagic)(frequently hemorrhagic)  Vasospasm: Rare, but common afterVasospasm: Rare, but common after subarachnoid hemorrhagesubarachnoid hemorrhage  Hypertensive vasculopathy: LacunarHypertensive vasculopathy: Lacunar infarctsinfarcts
  • 24. RISK FACTOR: atherosclerosisRISK FACTOR: atherosclerosis
  • 26. RISK FACTORS:RISK FACTORS: hypertension (lacunar infarcts)hypertension (lacunar infarcts) Lacunar infarct of theLacunar infarct of the globus pallidusglobus pallidus Lacunar infarct of theLacunar infarct of the ponspons
  • 27. Other causes of ischemiaOther causes of ischemia  Systemic Hypotension: Results in watershedSystemic Hypotension: Results in watershed infarctsinfarcts  Hypoxia or Anoxia: Lack of oxygen or poorHypoxia or Anoxia: Lack of oxygen or poor perfusion after MI results in watershed infarctsperfusion after MI results in watershed infarcts and/or damage in vulnerable regions, ieand/or damage in vulnerable regions, ie hippocampus and cerebellumhippocampus and cerebellum  Venous thrombosis: Rare, causes hemorrhagicVenous thrombosis: Rare, causes hemorrhagic infarcts, consider coagulopathyinfarcts, consider coagulopathy
  • 28. ANASTOMOSES BETWEENANASTOMOSES BETWEEN TERMINAL BRANCHES OFTERMINAL BRANCHES OF MAJOR CEREBRAL ARTERIESMAJOR CEREBRAL ARTERIES
  • 31. VENOUS INFARCTIONVENOUS INFARCTION  Venous infarction usuallyVenous infarction usually results from venous sinusresults from venous sinus thrombosisthrombosis  Risk factors include aRisk factors include a number of states thatnumber of states that result in hyperviscosityresult in hyperviscosity or increased coagulabilityor increased coagulability  Grossly they are veryGrossly they are very hemorrhagichemorrhagic
  • 32. Transient Ischemic AttacksTransient Ischemic Attacks  Lasts less than 24 hours by definitionLasts less than 24 hours by definition  Attributed to transient embolizationAttributed to transient embolization  Occurs in patients with atheroscleroticOccurs in patients with atherosclerotic stenosisstenosis  Harbinger of cerebral infarctionHarbinger of cerebral infarction
  • 33. Summary: Strokes due toSummary: Strokes due to ischemia/infarctionischemia/infarction  Large vessel atherosclerotic disease (non-Large vessel atherosclerotic disease (non- hemorrhagic)hemorrhagic)  Embolic (hemorrhagic)Embolic (hemorrhagic)  Hypertensive (hemorrhages and lacunes)Hypertensive (hemorrhages and lacunes)  Vasospasm (2° to subarachnoid hemorrhage)Vasospasm (2° to subarachnoid hemorrhage)  Watershed infarcts: hypotension and hypoxiaWatershed infarcts: hypotension and hypoxia  Venous thrombosis (rare, hemorrhagic)Venous thrombosis (rare, hemorrhagic)  TIA: clears in 24 hours -by definition, oftenTIA: clears in 24 hours -by definition, often associated with large vessel diseaseassociated with large vessel disease
  • 34. Strokes Due toStrokes Due to HemorrhageHemorrhage HypertensionHypertension AneurysmsAneurysms Vascular MalformationsVascular Malformations Bleeding DiathesisBleeding Diathesis TraumaTrauma
  • 37. SUBARACHNOID HEMORRHAGESUBARACHNOID HEMORRHAGE rupture of saccular (berry) aneurysmrupture of saccular (berry) aneurysm
  • 39. VASCULAR MALFORMATIONVASCULAR MALFORMATION AS A SOURCE OF HEMORRHAGEAS A SOURCE OF HEMORRHAGE arteriovenous malformation (AVM)arteriovenous malformation (AVM)
  • 40. BLOOD DYSCRASIASBLOOD DYSCRASIAS AS A CAUSE OF HEMORRHAGEAS A CAUSE OF HEMORRHAGE thrombocytopeniathrombocytopenia
  • 41. Summary: Strokes due toSummary: Strokes due to hemorrhagehemorrhage  Hypertension: Most common cause of brainHypertension: Most common cause of brain hemorrhage, sites include basal ganglia, pons,hemorrhage, sites include basal ganglia, pons, cerebellum and cerebral white mattercerebellum and cerebral white matter  Aneurysms:Aneurysms:  Berry aneurysm: Most common type, causesBerry aneurysm: Most common type, causes SAHSAH  Mycotic aneurysm: Rare, parenchymal bleed, bacterialMycotic aneurysm: Rare, parenchymal bleed, bacterial  Atherosclerotic: Rarely bleed, may cause mass effect,Atherosclerotic: Rarely bleed, may cause mass effect, fusiformfusiform  Vascular malformations and clottingVascular malformations and clotting abnormalitiesabnormalities
  • 42. Closed Head InjuryClosed Head Injury ConcussionConcussion  Immediate and temporary disturbance of brainImmediate and temporary disturbance of brain function.function.  Grading (1.Grading (1. mildmild: no LOC/smpt <15 min, 2.: no LOC/smpt <15 min, 2. modmod: no LOC/smpt >15min, 3.: no LOC/smpt >15min, 3. severesevere: any LOC): any LOC)  CauseCause  Shearing of axonsShearing of axons  Signs: Amnesia, confusion, headache, visualSigns: Amnesia, confusion, headache, visual disturbances, nausea, vomiting, dizzinessdisturbances, nausea, vomiting, dizziness
  • 43. Closed Head InjuryClosed Head Injury  Epidural hematomaEpidural hematoma: Middle meningeal artery: Middle meningeal artery tear (temporal bone fracture), accumulatestear (temporal bone fracture), accumulates rapidly (arterial)rapidly (arterial)  Subdural hematomaSubdural hematoma: Shearing of bridging: Shearing of bridging veins, accumulate in hours to days (rarelyveins, accumulate in hours to days (rarely weeks+)weeks+)  Subarachnoid hemorrhageSubarachnoid hemorrhage: Occurs with: Occurs with contusions or intraparenchymal hemorrhagecontusions or intraparenchymal hemorrhage (also with berry aneurysms)(also with berry aneurysms)
  • 44. TRAUMA AS A CAUSE OFTRAUMA AS A CAUSE OF HEMORRHAGEHEMORRHAGE subdural hematomasubdural hematoma
  • 45. Closed Head InjuryClosed Head Injury  ContusionsContusions: Brain against bone, coup (at site: Brain against bone, coup (at site of impact)/contrecoup (side opposite impact)of impact)/contrecoup (side opposite impact)  Intracerebral hemorrhageIntracerebral hemorrhage: Shearing of brain: Shearing of brain vessels, high impactvessels, high impact  Diffuse Axonal InjuryDiffuse Axonal Injury: Shearing of axons: Shearing of axons results in post-traumatic neurologic deficitsresults in post-traumatic neurologic deficits  Cerebral EdemaCerebral Edema: Occurs with and without an: Occurs with and without an obvious structural lesionobvious structural lesion  Note: Can occur without evidence of hemorrhageNote: Can occur without evidence of hemorrhage
  • 46. TRAUMA AS A CAUSE OFTRAUMA AS A CAUSE OF HEMORRHAGE: contusionsHEMORRHAGE: contusions
  • 47. Other traumatic injuriesOther traumatic injuries  Penetrating injuries: Bullets, bone fragments,Penetrating injuries: Bullets, bone fragments, result in laceration with the potential forresult in laceration with the potential for infectioninfection  Spinal cord injury: Fractures, vertebralSpinal cord injury: Fractures, vertebral dislocation, penetrating injury, the spinal corddislocation, penetrating injury, the spinal cord may be crushed or the site of hemorrhagemay be crushed or the site of hemorrhage
  • 48. Summary: TraumaSummary: Trauma  Closed head injuries:Closed head injuries:  Sites (epidural, subdural, subarachnoid,Sites (epidural, subdural, subarachnoid, parenchymal) and typical etiologyparenchymal) and typical etiology  Contusion, hemorrhage, diffuse axonal injury,Contusion, hemorrhage, diffuse axonal injury, edemaedema  Penetrating injuries:Penetrating injuries:  Causes and risks (infection)Causes and risks (infection)  Spinal cord injuriesSpinal cord injuries
  • 50. Infections: Route of entryInfections: Route of entry  Hematogenous (most common)Hematogenous (most common)  Localized source: abscess, heart valve, lung infectionLocalized source: abscess, heart valve, lung infection  Other: mosquitos, needlesOther: mosquitos, needles  Direct implantation (trauma)Direct implantation (trauma)  Local extension (ear infectionLocal extension (ear infection abscess)abscess)  Axonal transport (rabies, HSV)Axonal transport (rabies, HSV)
  • 51. MeningitisMeningitis  Inflammation of the meningesInflammation of the meninges  FeverFever  HeadacheHeadache  Stiff neckStiff neck  Decreased level of consciousnessDecreased level of consciousness  Bacterial (purulent)Bacterial (purulent)  Tuberculous (granulomatous)Tuberculous (granulomatous)  Fungal (granulomatous)Fungal (granulomatous)
  • 52. Bacterial MeningitisBacterial Meningitis  Neonates: E. Coli, group B streptococciNeonates: E. Coli, group B streptococci  Infants and children: Hemophilus influenzaInfants and children: Hemophilus influenza (before immunization)(before immunization)  Young adults: Neisseria meningitidisYoung adults: Neisseria meningitidis  Adults: Streptococcus pneumoniae and ListeriaAdults: Streptococcus pneumoniae and Listeria monocytogenesmonocytogenes
  • 53. Meningitis: CSF findingsMeningitis: CSF findings  Increased white blood cellsIncreased white blood cells  Neutrophils withNeutrophils with bacterialbacterial meningitismeningitis  Mononuclear cells (lymphocytes andMononuclear cells (lymphocytes and macrophages) withmacrophages) with TB and fungalTB and fungal infectionsinfections  Lymphocytes withLymphocytes with viralviral infectioninfection  Increased protein (mild with viral)Increased protein (mild with viral)  Reduced glucose withReduced glucose with bacterialbacterial meningitismeningitis
  • 60. Cerebral AbscessCerebral Abscess  Localized (contained) infectionLocalized (contained) infection  Hematogenous spread (heart valves), penetratingHematogenous spread (heart valves), penetrating wound, paranasal sinuses, middle earwound, paranasal sinuses, middle ear  Oral flora may be the source of an abscess afterOral flora may be the source of an abscess after dental manipulationdental manipulation  Organisms are mixed and frequently anaerobicOrganisms are mixed and frequently anaerobic  Surrounding cerebral edema is commonSurrounding cerebral edema is common  CSF is frequently sterileCSF is frequently sterile
  • 62. Cerebritis in Immune-compromisedCerebritis in Immune-compromised PatientsPatients  Fungal InfectionsFungal Infections  AspergillusAspergillus  CandidaCandida  MucorMucor  ProtozoalProtozoal  ToxoplasmaToxoplasma  Ameba infections can be seen inAmeba infections can be seen in immunocompromised patients and rarelyimmunocompromised patients and rarely non-immunocompromised individualsnon-immunocompromised individuals
  • 63. Viral infectionViral infection  Route of entryRoute of entry  May be blood borne, respiratory or fecal/oralMay be blood borne, respiratory or fecal/oral  Rabies-peripheral nerveRabies-peripheral nerve  Acute viral encephalitisAcute viral encephalitis  Herpes-activation of latent infectionHerpes-activation of latent infection  Arbovirus-mosquito borne (West Nile virus)Arbovirus-mosquito borne (West Nile virus)  Polio-enteric virus with neuronal tropismPolio-enteric virus with neuronal tropism  Immunocompromised hostsImmunocompromised hosts  CMVCMV  HSV/VZVHSV/VZV  PMLPML  HIV encephalitis (HIVE)HIV encephalitis (HIVE)
  • 64. ACUTE (VIRAL) ENCEPHALITISACUTE (VIRAL) ENCEPHALITIS microscopic featuresmicroscopic features Lymphocytic infiltratesLymphocytic infiltrates Microglial proliferationMicroglial proliferation with microglial noduleswith microglial nodules
  • 65. ACUTE (VIRAL) ENCEPHALITISACUTE (VIRAL) ENCEPHALITIS Herpes simplexHerpes simplex
  • 66. OPPORTUNISTIC VIRAL INFECTIONS:OPPORTUNISTIC VIRAL INFECTIONS: Progressive multifocal leukoencephalopathyProgressive multifocal leukoencephalopathy (JC virus)(JC virus)
  • 70. OPPORTUNISTICOPPORTUNISTIC INFECTIONSINFECTIONS ToxoplasmosisToxoplasmosis Necrotizing lesionNecrotizing lesion Immunoperoxidase forImmunoperoxidase for H&EH&E Toxo. tachyzoitesToxo. tachyzoites
  • 71. OPPORTUNISTIC INFECTIONSOPPORTUNISTIC INFECTIONS Fungal cerebritis : AspergillusFungal cerebritis : Aspergillus
  • 72. OPPORTUNISTIC INFECTIONSOPPORTUNISTIC INFECTIONS Fungal cerebritis : AspergillusFungal cerebritis : Aspergillus
  • 73. Summary: InfectionsSummary: Infections  Meningitis: Definition, CSF findingsMeningitis: Definition, CSF findings  Abscess: Definition, etiologyAbscess: Definition, etiology  Viral meningitis: Routes of entry (arbo-Viral meningitis: Routes of entry (arbo- mosquitos)mosquitos)  Viral encephalitis: Rabies, HSV, arbovirusesViral encephalitis: Rabies, HSV, arboviruses  Spinal cord: PolioSpinal cord: Polio  Infections in immunocompromised hostsInfections in immunocompromised hosts  Cerebritis: Fungal (aspergillus, protozoal-Cerebritis: Fungal (aspergillus, protozoal- toxoplasma)toxoplasma)  Viral: CMV, VZV, PML, Aids encephalopathyViral: CMV, VZV, PML, Aids encephalopathy
  • 74. Primary Tumors of the CentralPrimary Tumors of the Central Nervous SystemNervous System GliomaGlioma AstrocytomaAstrocytoma OligodendrogliomaOligodendroglioma EpendymomaEpendymoma  Neuronal lineageNeuronal lineage  MeningiomaMeningioma  Nerve Sheath TumorsNerve Sheath Tumors
  • 75. Primary brain tumors: Cell typesPrimary brain tumors: Cell types 1.1. Neuron:Neuron: Gangliocytoma, gangliogliomaGangliocytoma, ganglioglioma medulloblastomamedulloblastoma 2.2. AstrocyteAstrocyte:: Astrocytoma, glioblastomaAstrocytoma, glioblastoma 3.3. OligodendrocyteOligodendrocyte:: OligodendrogliomaOligodendroglioma 4.4. Ependymal cellEpendymal cell:: EpendymomaEpendymoma 5.5. Microglial cellMicroglial cell:: Tumors derived from microglialTumors derived from microglial cells have not been described.cells have not been described. 6.6. Meningeal cellMeningeal cell:: Meningiomas are derived fromMeningiomas are derived from arachnoidal cells and are usually dural-based.arachnoidal cells and are usually dural-based.
  • 77. GliomasGliomas  Diffusely infiltrating (not easily resected)Diffusely infiltrating (not easily resected)  Histologic appearance (grade) correlates withHistologic appearance (grade) correlates with overall survivaloverall survival  May become more malignant (higher grade) overMay become more malignant (higher grade) over time (especially astrocytomas which becometime (especially astrocytomas which become glioblastomas)glioblastomas)  May spread via CSFMay spread via CSF  Rarely (never) metastasizeRarely (never) metastasize
  • 79. JUVENILE PILOCYTICJUVENILE PILOCYTIC ASTROCYTOMAASTROCYTOMA Rosenthal fibersRosenthal fibers Eosinophilic granularEosinophilic granular bodiesbodies
  • 83. ASTROCYTOMAASTROCYTOMA FEATURES OF ANAPLASIAFEATURES OF ANAPLASIA vascular proliferationvascular proliferation
  • 88. Non-glial tumorsNon-glial tumors  Medulloblastoma: Malignant cerebellar tumorMedulloblastoma: Malignant cerebellar tumor of childhoodof childhood  Meningioma: Benign, superficial, well-Meningioma: Benign, superficial, well- circumscribed tumor derived from arachnoidalcircumscribed tumor derived from arachnoidal cellscells  Nerve sheath tumors: Schwannoma andNerve sheath tumors: Schwannoma and neurofibroma, well-circumscribed, encapsulatedneurofibroma, well-circumscribed, encapsulated tumors involving cranial nerves, spinal nervestumors involving cranial nerves, spinal nerves and other peripheral nervesand other peripheral nerves
  • 94. Secondary Involvement of theSecondary Involvement of the Central Nervous SystemCentral Nervous System  Metastatic tumorMetastatic tumor  MelanomaMelanoma  Renal cellRenal cell  LungLung  Contiguous involvement (pituitaryContiguous involvement (pituitary adenoma and craniopharyngioma)adenoma and craniopharyngioma)
  • 95. METASTATIC TUMORSMETASTATIC TUMORS leptomeningeal carcinomatosisleptomeningeal carcinomatosis
  • 98. Summary: Brain tumorsSummary: Brain tumors  Primary brain tumors: glia (low grade vs. highPrimary brain tumors: glia (low grade vs. high grade), neurons, meningesgrade), neurons, meninges  Nerve sheath tumors: schwannoma andNerve sheath tumors: schwannoma and neurofibromaneurofibroma  Secondary brain tumors: Metastatic (lung-males,Secondary brain tumors: Metastatic (lung-males, breast-females, melanoma, renal cell carcinoma)breast-females, melanoma, renal cell carcinoma)  Tumors arising outside the CNS with CNSTumors arising outside the CNS with CNS symptoms: pituitary adenoma,symptoms: pituitary adenoma, craniopharyngiomacraniopharyngioma
  • 99. DISEASES OF MYELINDISEASES OF MYELIN AND PERIPHERALAND PERIPHERAL NERVENERVE
  • 100. MYELINMYELIN PNS MYELINPNS MYELIN CNSCNS MYELINMYELIN
  • 102. DISEASES OF MYELINDISEASES OF MYELIN  DEMYELINATING DISEASES:DEMYELINATING DISEASES:  Acquired disorders of myelin, such as multipleAcquired disorders of myelin, such as multiple sclerosis.sclerosis.  DYSMYELINATING DISEASES:DYSMYELINATING DISEASES:  Genetic disorders of myelin and its turnover,Genetic disorders of myelin and its turnover, such as leukodystrophiessuch as leukodystrophies
  • 103. MULTIPLE SCLEROSISMULTIPLE SCLEROSIS  Multiple sclerosis is the most common diseaseMultiple sclerosis is the most common disease of CNS myelin; prevalence of 1:1000.of CNS myelin; prevalence of 1:1000.  Central nervous system myelin is selectivelyCentral nervous system myelin is selectively destroyed (axons are relatively preserved)destroyed (axons are relatively preserved)  Onset is frequently in 30 and 40 year old ageOnset is frequently in 30 and 40 year old age groups.groups.  The disease is typically progressive with relapsingThe disease is typically progressive with relapsing and remitting accumulations of focal neurologicand remitting accumulations of focal neurologic deficits.deficits.  The etiology is thought to be autoimmune inThe etiology is thought to be autoimmune in naturenature
  • 108. PONTINE MS PLAQUEPONTINE MS PLAQUE adjacent sections for myelin andadjacent sections for myelin and axonsaxons  Luxol fast-blue-PASLuxol fast-blue-PAS BielschowskyBielschowsky
  • 109. MULTIPLE SCLEROSIS PLAQUEMULTIPLE SCLEROSIS PLAQUE sharp circumscriptionsharp circumscription
  • 110. ACUTE DISSEMINATEDACUTE DISSEMINATED ENCEPHALOMYELITISENCEPHALOMYELITIS  Post- or parainfectious encephalomyelitis:Post- or parainfectious encephalomyelitis:  following a viral infectionfollowing a viral infection  Postvaccinial encephalomyelitis:Postvaccinial encephalomyelitis:  Pasteur rabies and smallpox vaccinationPasteur rabies and smallpox vaccination  Akin to EAE (experimental allergic enceph.)Akin to EAE (experimental allergic enceph.)  ADE is an acute, monophasic illnessADE is an acute, monophasic illness  Pathology:Pathology:  Perivenous lymphocytic infiltrates withPerivenous lymphocytic infiltrates with demyelinationdemyelination  Autoimmune mechanismAutoimmune mechanism
  • 111. ACUTE DISSEMINATEDACUTE DISSEMINATED ENCEPHALOMYELITISENCEPHALOMYELITIS (ADEM)(ADEM) H & EH & E Myelin basicMyelin basic protein IHCprotein IHC
  • 113. Myasthenia GravisMyasthenia Gravis  An autoimmune neuromuscular disease that resultsAn autoimmune neuromuscular disease that results from autoantibodies at the neuromuscular junction.from autoantibodies at the neuromuscular junction.  Characterized by variable weakness of voluntary muscles (eyeCharacterized by variable weakness of voluntary muscles (eye muscles may be weak)muscles may be weak)  Worsens with activity (and late in the day)Worsens with activity (and late in the day)  May be associated with other autoimmune disordersMay be associated with other autoimmune disorders such as thyroid disease, rheumatoid arthritis and SLEsuch as thyroid disease, rheumatoid arthritis and SLE  Often associated with a thymoma, removal of theOften associated with a thymoma, removal of the thymoma may be curative.thymoma may be curative.
  • 114. LEUKODYSTROPHIESLEUKODYSTROPHIES  CLINICAL: A variety of inherited diseases withCLINICAL: A variety of inherited diseases with variable age of onset (usually in childhood) andvariable age of onset (usually in childhood) and rate of progression, which typically result inrate of progression, which typically result in diffuse severe dysfunction.diffuse severe dysfunction.  PATHOGENESIS:PATHOGENESIS: Recessive mutations inRecessive mutations in proteins related to myelin structure orproteins related to myelin structure or metabolismmetabolism  The peripheral nervous system also may beThe peripheral nervous system also may be involved in a number of formsinvolved in a number of forms
  • 115. PATHOLOGY OFPATHOLOGY OF LEUKODYSTROPHIESLEUKODYSTROPHIES  Demyelination in large confluent foci within the cerebralDemyelination in large confluent foci within the cerebral hemispheres and other siteshemispheres and other sites  GENERAL:GENERAL: 1.1. Loss of myelin and oligodendrogliaLoss of myelin and oligodendroglia 2.2. Relative preservation of axonsRelative preservation of axons  DISEASE SPECIFIC:DISEASE SPECIFIC: 1.1. Globoid cells (Krabbe’s disease)Globoid cells (Krabbe’s disease) 2.2. Metachromatic material in macrophages and neuronsMetachromatic material in macrophages and neurons (metachromatic leukodystrophy, aryl sulfatase deficient)(metachromatic leukodystrophy, aryl sulfatase deficient) 3.3. Adrenal atrophy and cytosomal inclusions (ALD,Adrenal atrophy and cytosomal inclusions (ALD, peroxisomal abnormality)peroxisomal abnormality)
  • 117. METACHROMATICMETACHROMATIC LEUKODYSTROPHYLEUKODYSTROPHY sparing of subcortical arcuate fiberssparing of subcortical arcuate fibers
  • 118. METACHROMATICMETACHROMATIC LEUKODYSTROPHYLEUKODYSTROPHY (aryl sulfatase deficiency)(aryl sulfatase deficiency) Acidified cresyl violetAcidified cresyl violet LFB-PASLFB-PAS metachromasiametachromasia
  • 121. KRABBE’S DISEASEKRABBE’S DISEASE (GLOBOID CELL(GLOBOID CELL LEUKODYSTROPHY)LEUKODYSTROPHY) cerebroside-cerebroside-ββ-galactosidase deficiency-galactosidase deficiency
  • 122. DISEASES OF PERIPHERALDISEASES OF PERIPHERAL NERVENERVE CLASSIFICATION BY PATHOLOGYCLASSIFICATION BY PATHOLOGY Demyelinating neuropathiesDemyelinating neuropathies Guillain-Barre-Landry syndromeGuillain-Barre-Landry syndrome Chronic inflammatory demyelinating polyneuropathyChronic inflammatory demyelinating polyneuropathy (CIDP)(CIDP) Axonal neuropathies: most neuropathies areAxonal neuropathies: most neuropathies are axonal but pathology often is nonspecificaxonal but pathology often is nonspecific Examples include hypertrophic neuropathies,Examples include hypertrophic neuropathies, herpes zoster, HIV, alcoholic and diabeticherpes zoster, HIV, alcoholic and diabetic neuropathiesneuropathies
  • 126. Summary:Summary: Demyelinating/DysmyelinatingDemyelinating/Dysmyelinating diseasesdiseases  Demyelinating disease: most common is MS,Demyelinating disease: most common is MS, acute disseminated encephalomyelitis (rare,acute disseminated encephalomyelitis (rare, follows viral infection, vaccination)follows viral infection, vaccination)  Leukodystrophies: Genetic diseases (manyLeukodystrophies: Genetic diseases (many enzyme abnormalities are defined) resulting inenzyme abnormalities are defined) resulting in myelin loss, occur early in life.myelin loss, occur early in life.  Peripheral nerve demyelination: Guillain-BarrePeripheral nerve demyelination: Guillain-Barre Syndrome, autoimmune, potential forSyndrome, autoimmune, potential for remyelination with complete recoveryremyelination with complete recovery
  • 127. NeurodegenerativeNeurodegenerative diseasesdiseases Dementia:Dementia: Alzheimer’s disease, Pick’s diseaseAlzheimer’s disease, Pick’s disease Movement Disorders:Movement Disorders: Parkinson’s disease, Huntington’sParkinson’s disease, Huntington’s disease, Multiple Systems Atrophydisease, Multiple Systems Atrophy Motor Disease:Motor Disease: ALS, Werdnig-Hoffman, PoliomyelitisALS, Werdnig-Hoffman, Poliomyelitis Prion diseasePrion disease
  • 128. Alzheimer’s disease: ClinicalAlzheimer’s disease: Clinical featuresfeatures  Clinical features of dementiaClinical features of dementia  Impairment of recent memoryImpairment of recent memory  Aphasia (naming), apraxia (motor), agnosiaAphasia (naming), apraxia (motor), agnosia (object), executive functioning(object), executive functioning  Impaired level of functionImpaired level of function  Progressive over timeProgressive over time  47% of people over 85 years of age are47% of people over 85 years of age are affectedaffected
  • 129. Alzheimer’s disease: PathogenesisAlzheimer’s disease: Pathogenesis  The amyloid hypothesis:The amyloid hypothesis: Abnormal APP processingAbnormal APP processing leads to deposits ofleads to deposits of insoluble B-pleatedinsoluble B-pleated amyloid proteinamyloid protein
  • 130. Alzheimer’s disease: Gross andAlzheimer’s disease: Gross and microscopic featuresmicroscopic features  Gross brain atrophy: neuronal lossGross brain atrophy: neuronal loss  Neuritic (senile) plaquesNeuritic (senile) plaques containingcontaining B-B- amyloidamyloid  Neurofibrillary tanglesNeurofibrillary tangles composed ofcomposed of phosphorylated microtubule associatedphosphorylated microtubule associated tautau proteinprotein  Cerebral amyloidosisCerebral amyloidosis
  • 131.
  • 132.
  • 133.
  • 134.
  • 135.
  • 136. Other DementiasOther Dementias  Dementia with Lewy bodiesDementia with Lewy bodies  Second most common neurodegenerative cause ofSecond most common neurodegenerative cause of dementiadementia  Lewy bodies and neurodegeneration affect brainstemLewy bodies and neurodegeneration affect brainstem and cortexand cortex  Pick’s disease and other frontal temporalPick’s disease and other frontal temporal dementiasdementias  Classification depends on histologic examination andClassification depends on histologic examination and is complicatedis complicated
  • 137. Parkinson’s disease: ClinicalParkinson’s disease: Clinical findingsfindings  Idiopathic Parkinson’s disease (vs.Idiopathic Parkinson’s disease (vs. parkinsonism or parkinsonian syndrome),parkinsonism or parkinsonian syndrome), est 1% of population over 50 years of ageest 1% of population over 50 years of age  TremorTremor (rest)(rest)  RigidityRigidity (cogwheel rigidity)(cogwheel rigidity)  BradykinesiaBradykinesia (mask-like facies, loss of arm-(mask-like facies, loss of arm- swing)swing)  Festinating gait (loss of righting reflexes)Festinating gait (loss of righting reflexes)
  • 138. Parkinson’s disease: Gross andParkinson’s disease: Gross and microscopic findingsmicroscopic findings  Gross--Gross--loss of pigmentloss of pigment in thein the substantiasubstantia nigranigra  Microscopic--Lewy bodies with pigmentedMicroscopic--Lewy bodies with pigmented neuronal cell loss and gliosisneuronal cell loss and gliosis  cortical Lewy bodies present in 80% or morecortical Lewy bodies present in 80% or more of PD casesof PD cases
  • 140.
  • 141.
  • 142. Other Extrapyramidal MovementOther Extrapyramidal Movement DisordersDisorders  Parkinson’s disease: HypokineticParkinson’s disease: Hypokinetic  Huntington’s disease: HyperkineticHuntington’s disease: Hyperkinetic  Choreiform movementsChoreiform movements  Intellectual declineIntellectual decline  Multiple Systems AtrophyMultiple Systems Atrophy  Parkinsonian featuresParkinsonian features  Symptoms suggestive of olivopontocerebellarSymptoms suggestive of olivopontocerebellar degenerationdegeneration  Shy-Drager syndrome (parasympathetic dysfunction)Shy-Drager syndrome (parasympathetic dysfunction)
  • 143. Motor neuron diseaseMotor neuron disease  Amyotrophic lateral sclerosis (Lou Gehrig’sAmyotrophic lateral sclerosis (Lou Gehrig’s disease)disease)  Results in progressive weakness, eventually resultingResults in progressive weakness, eventually resulting in paralysis of respiratory muscles and death oftenin paralysis of respiratory muscles and death often within 2-5 years of diagnosiswithin 2-5 years of diagnosis  Degeneration of upper (motor cortex) and lowerDegeneration of upper (motor cortex) and lower (spinal cord) motor neurons(spinal cord) motor neurons
  • 144. Motor Neuron DiseaseMotor Neuron Disease  ALS: Adult form of motor neuron diseaseALS: Adult form of motor neuron disease associated with both upper (brain) and lowerassociated with both upper (brain) and lower (spinal cord) motor involvement(spinal cord) motor involvement  Werdnig-Hoffman disease: The baby is weakWerdnig-Hoffman disease: The baby is weak (floppy) at birth. Lower (spinal cord) motor(floppy) at birth. Lower (spinal cord) motor neurons are involved.neurons are involved.  Poliomyelitis: Lower motor neurons arePoliomyelitis: Lower motor neurons are destroyed.destroyed.
  • 145. Prion disease (SpongiformPrion disease (Spongiform encephalopathy): Clinical findingsencephalopathy): Clinical findings  50-70 years old,50-70 years old, rapidly evolving dementiarapidly evolving dementia,, often withoften with myoclonusmyoclonus and a characteristic EEGand a characteristic EEG pattern (of repetitive sharp waves)pattern (of repetitive sharp waves)  Early symptoms include personality changes,Early symptoms include personality changes, impaired judgement, gait abnormalities, vertigo,impaired judgement, gait abnormalities, vertigo,  In some patients cerebellar and visualIn some patients cerebellar and visual abnormalities predominateabnormalities predominate  MajorityMajority die w/in 6 monthsdie w/in 6 months, frequently w/in 3, frequently w/in 3 mo.mo.
  • 146. Prion disease: PathogenesisPrion disease: Pathogenesis  Transmissible but not “infectious”Transmissible but not “infectious”  Prion proteinPrion protein, Prusiner--1997 Nobel Prize, (not a, Prusiner--1997 Nobel Prize, (not a “slow virus”)“slow virus”)  PrPPrPCC -- produced normally in most cells --amino acid-- produced normally in most cells --amino acid sequence is identical to the PrPsequence is identical to the PrPSCSC --abnormal protein, the--abnormal protein, the difference is in the secondary conformation (B-pleateddifference is in the secondary conformation (B-pleated vs alpha helical) PrPvs alpha helical) PrPSCSC causes post-translationalcauses post-translational modification of PrPmodification of PrPCC  Transmitted by direct inoculation (corneal transplants,Transmitted by direct inoculation (corneal transplants, dural grafts, pituitary products)dural grafts, pituitary products)
  • 147. Prion disease: Gross andPrion disease: Gross and microscopic findingsmicroscopic findings  Gross appearance--may be normal due toGross appearance--may be normal due to short duration of diseaseshort duration of disease  Microscopic appearance--vacuolation ofMicroscopic appearance--vacuolation of neuropil, vacuoles are within nerve cellneuropil, vacuoles are within nerve cell bodies and neuronal processesbodies and neuronal processes  cell loss and gliosis may be prominentcell loss and gliosis may be prominent
  • 149. Summary: NeurodegenerativeSummary: Neurodegenerative diseasesdiseases  DementiaDementia  Alzheimer’s disease: common, amyloid hypothesis, plaquesAlzheimer’s disease: common, amyloid hypothesis, plaques and tangles, gross brain atrophyand tangles, gross brain atrophy  Prion disease: rare, “transmissible” protein, rapidlyPrion disease: rare, “transmissible” protein, rapidly progressive, vacuolar changesprogressive, vacuolar changes  Movement disordersMovement disorders  Parkinson’s disease: hypokinetic, loss of dopaminergic cellsParkinson’s disease: hypokinetic, loss of dopaminergic cells substantia nigra, Lewy bodiessubstantia nigra, Lewy bodies  Huntington’s disease: choreiform movements, caudateHuntington’s disease: choreiform movements, caudate atrophy, nuclear inclusionsatrophy, nuclear inclusions  Motor neuron disease (ALS): Loss of upper and lowerMotor neuron disease (ALS): Loss of upper and lower motor neurons, progressive over 2-5 yearsmotor neurons, progressive over 2-5 years
  • 150. PediatricPediatric NeuropathologyNeuropathology Developmental AbnormalitiesDevelopmental Abnormalities Neuronal Storage DiseasesNeuronal Storage Diseases Familial Tumor SyndromesFamilial Tumor Syndromes Perinatal Lesions/InfectionsPerinatal Lesions/Infections Trauma: shaken baby syndromeTrauma: shaken baby syndrome
  • 151. Developmental Abnormalities:Developmental Abnormalities: PathologyPathology  Organ inductionOrgan induction (2.5-6 weeks): neural tube defects:(2.5-6 weeks): neural tube defects: anencephaly, spinal dysraphism, encephalocele,anencephaly, spinal dysraphism, encephalocele, holoprosencephalyholoprosencephaly  Neuronal (glial) migrationNeuronal (glial) migration (3-6 months):(3-6 months): lissencephaly, microcephaly, polymicrogyria, agenesis oflissencephaly, microcephaly, polymicrogyria, agenesis of the corpus callosumthe corpus callosum  MyelinationMyelination (2 months-juvenile)(2 months-juvenile)  SynaptogenesisSynaptogenesis (20 week gestation-adulthood):(20 week gestation-adulthood): trisomy 21, fragile X, cretinismtrisomy 21, fragile X, cretinism In general,In general, earlier insults cause more severe structuralearlier insults cause more severe structural damagedamage
  • 152. Organ Induction:Organ Induction: Dysraphic DisordersDysraphic Disorders  Failure of neural tube folds to close duringFailure of neural tube folds to close during developmentdevelopment  Prenatal testing may reveal an elevated maternal serumPrenatal testing may reveal an elevated maternal serum AFPAFP  Folate deficiency: Folic acid supplementation prior toFolate deficiency: Folic acid supplementation prior to conception may reduce the incidence of neural tubeconception may reduce the incidence of neural tube defects up to 70%defects up to 70%  Neural tube defects range from small bony defects in theNeural tube defects range from small bony defects in the lumbosacral region (spina bifida occulta) tolumbosacral region (spina bifida occulta) to craniorachischisis.craniorachischisis.  Myelomeningoceles occur most commonly in theMyelomeningoceles occur most commonly in the lumbosacral regionlumbosacral region
  • 153.
  • 154.
  • 155.
  • 156. Neuronal migration disordersNeuronal migration disorders  Lissencephaly (smooth brain)/pachygyria (fewLissencephaly (smooth brain)/pachygyria (few enlarged gyrienlarged gyri  Polymicrogyria (many small gyri)Polymicrogyria (many small gyri)  Heterotopias (circumscribed collections) andHeterotopias (circumscribed collections) and dysplasias (disorganized lamination)dysplasias (disorganized lamination)  Occur with other developmental abnormalities forOccur with other developmental abnormalities for example in patients with chromosomal abnormalitiesexample in patients with chromosomal abnormalities  May be the focus of seizure activityMay be the focus of seizure activity
  • 157. SeizuresSeizures  Result from abnormal electrical activity of a group ofResult from abnormal electrical activity of a group of brain cells and cause an altered mental state or tonicbrain cells and cause an altered mental state or tonic clonic movements. May be partial (focal) orclonic movements. May be partial (focal) or generalized.generalized.  In children seizures may result from neuronal migrationIn children seizures may result from neuronal migration abnormalities or from abnormalities acquiredabnormalities or from abnormalities acquired subsequent to brain damage (such as inflammation)subsequent to brain damage (such as inflammation)  A first time seizure in an adult would warrant anA first time seizure in an adult would warrant an imaging study to rule out tumor or other structuralimaging study to rule out tumor or other structural abnormalityabnormality
  • 158.
  • 159.
  • 160. Neuronal Storage DiseaseNeuronal Storage Disease  Result from inborn errors of metabolism (deficientResult from inborn errors of metabolism (deficient enzyme or abnormal lysosomal function)enzyme or abnormal lysosomal function)  Progressive, poor treatment options (bone marrowProgressive, poor treatment options (bone marrow transplant)transplant)  Accumulation of metabolic products in the neuronAccumulation of metabolic products in the neuron  Tay Sachs diseaseTay Sachs disease  Neuronal ceroid lipofuscinosisNeuronal ceroid lipofuscinosis  Glycogen storage diseaseGlycogen storage disease
  • 161.
  • 162. Concentric Multilamellar membranous cytoplasmic bodies (MCB’s)
  • 163. Familial Tumor SyndromesFamilial Tumor Syndromes  NeurofibromatosisNeurofibromatosis  NF-1: (most common) multiple peripheral neurofibromasNF-1: (most common) multiple peripheral neurofibromas  NF-2: bilateral acoustic schwannomas and meningiomasNF-2: bilateral acoustic schwannomas and meningiomas  Tuberous Sclerosis: subcortical and corticalTuberous Sclerosis: subcortical and cortical hamaratomas(tubers)hamaratomas(tubers) -Autosomal dominant-Autosomal dominant -Tumor suppressor gene mutations-Tumor suppressor gene mutations -Cutaneous findings-Cutaneous findings
  • 164. Perinatal Lesions ofPerinatal Lesions of the CNSthe CNS HemorrhageHemorrhage Hypoxic/IschemicHypoxic/Ischemic InfectiousInfectious
  • 165.
  • 166.
  • 167. Congenital/Perinatal InfectionsCongenital/Perinatal Infections TORCHTORCH  ToxoplasmosisToxoplasmosis  Other: syphilis, TB, listeria monocytogenes;Other: syphilis, TB, listeria monocytogenes; other viruses (VZV, HepB)other viruses (VZV, HepB)  Rubella (rare—immunizations)Rubella (rare—immunizations)  Cytomegalovirus, Chlamydia trachomatisCytomegalovirus, Chlamydia trachomatis  Herpes simplex (usually type 2); HIVHerpes simplex (usually type 2); HIV
  • 168. Shaken Baby SyndromeShaken Baby Syndrome  General: Violent shaking causes accelerationGeneral: Violent shaking causes acceleration ((shearingshearing) injury of axons:) injury of axons: diffuse axonal injurydiffuse axonal injury  Neurologic: Blindness/mental retardation in infantsNeurologic: Blindness/mental retardation in infants less than 1 year of age. Present with apnea, seizures,less than 1 year of age. Present with apnea, seizures, lethargy, bradycardia, respiratory difficulty, coma.lethargy, bradycardia, respiratory difficulty, coma.  Pathology:Pathology: Oculo-cerebral damage can occurOculo-cerebral damage can occur without external evidence of head injury.without external evidence of head injury. RetinalRetinal and optic nerve sheath hemorrhage—and optic nerve sheath hemorrhage— ophthalmoscopic exam importantophthalmoscopic exam important  Microscopic: Axonal spheroidsMicroscopic: Axonal spheroids
  • 169. Summary: Pediatric neuropathologySummary: Pediatric neuropathology  Developmental abnormalities: Neural tubeDevelopmental abnormalities: Neural tube defects (anencephaly, spina bifida), migrationaldefects (anencephaly, spina bifida), migrational defects (mental retardation, seizures)defects (mental retardation, seizures)  Inborn errors of metabolism: Neuronal storageInborn errors of metabolism: Neuronal storage diseases and leukodystrophiesdiseases and leukodystrophies  Other: Familial tumor syndromes, hemorrhage,Other: Familial tumor syndromes, hemorrhage, hypoxic/ischemic injury, shaken baby syndromehypoxic/ischemic injury, shaken baby syndrome
  • 170. Pathology of the Nervous SystemPathology of the Nervous System  IntroductionIntroduction  IncreasedIncreased intracranialintracranial pressurepressure  Vascular andVascular and circulatorycirculatory disordersdisorders  TraumaTrauma  InfectionsInfections  TumorsTumors  DemyelinatingDemyelinating diseasesdiseases  DegenerativeDegenerative diseasesdiseases  DevelopmentalDevelopmental AbnormalitiesAbnormalities
  • 171.
  • 172. The more people IThe more people I meet…meet… The more I likeThe more I like my dogmy dog

Editor's Notes

  1. Alpha-fetoprotein (AFP), a substance naturally produced by the fetus&amp;apos;s liver. The level of AFP in the mother&amp;apos;s blood increases steadily during pregnancy. An abnormally high AFP level can be a sign of a neural tube defect. An abnormally low AFP level can be a sign of Down syndrome. Human chorionic gonadotropin (hCG), a hormone produced by the placenta when a woman becomes pregnant. The level of hCG steadily increases during the first 14 to 16 weeks of pregnancy, typically peaks around the 14th week, and then gradually decreases. Abnormally high hCG can be a sign of Down syndrome. Estriol, a form of estrogen that increases during pregnancy. It is produced in large amounts by the placenta. Estriol can be detected in the blood as early as the 9th week of pregnancy and continues to increase until delivery. Abnormally low estriol can be a sign of Down syndrome. Inhibin-A, a protein produced by the fetus and placenta. Abnormally high inhibin-A can be a sign of Down syndrome.